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ABSTRACT 
China has made great strides in controlling most common vaccine-preventable 
diseases by increasing access to childhood vaccines through the government-funded 
Expanded Program for Immunization. Despite this success, China was unable to meet the 
national and WHO goal of measles elimination by 2012, and has chosen to not publicly fund 
newer vaccines, like the pneumococcal vaccine. Non-locals, migrants from rural to urban 
areas, are generally thought to be a significant contributor to the difficulty in controlling 
vaccine preventable diseases in China because of their higher mobility and lower 
socioeconomic status. Using registry and survey data, we quantified differences in disease 
incidence between locals and non-locals. In the first study, we characterized differences in 
the measles incidence rate between locals and non-locals in a Poisson regression of time 
series data from Tianjin. We found that non-locals had a higher rate of measles before the 
2008 supplementary immunization activity (SIA), but this disparity attenuated in the two 
years after the first SIA and was completely eliminated after the 2010 SIA. In the second 
study, we used logistic regression models to examine patterns of measles and 
pneumococcal vaccination among children in the Shanghai immunization registry, in 
particular focusing on differences between locals and non-locals and on role of township-
level factors. Non-locals had less timely measles vaccines and lower uptake of 
pneumococcal vaccines, except for the pneumococcal polysaccharide vaccine. Children 
residing in non-local-majority townships also had less timely administration of measles 
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vaccines than those living in local-majority townships. For the third study, we surveyed 
parents in Shanghai, and compared parental perceptions of measles, pneumonia, and 
meningitis using a logistic regression model. Parents believed that measles and meningitis 
needed a vaccine more than pneumonia. Perceived prevalence of disease was not 
associated with vaccine necessity, and more non-locals believed the pneumonia vaccine to 
be necessary than locals. The findings from this dissertation help to identify the 
contribution of non-locals towards difficulties in controlling vaccine-preventable diseases 
in China, and this dissertation provides a framework for discussing what township-level 
variables and individual-level attitudes are associated with vaccination behaviors. 
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CHAPTER I 
Introduction to vaccine-preventable diseases in China 
 
  Vaccine-preventable diseases have remained an important, albeit declining, source 
of childhood morbidity and mortality worldwide over the last few decades. As a result of 
improved routine immunization programs and supplemental immunization activities 
(SIAs), annual, global deaths among all ages from 11 vaccine-preventable diseases1 
decreased from over 4 million in 1990 to under 2.7 million in 2010 [1]. Vaccinations are an 
important tool for disease elimination, the absence of transmission in a defined 
geographical area for over 1 year [2], and worldwide eradication. 
 Controlling diseases becomes much more difficult in the epidemic tail, when disease 
circulates at low levels [3]. The population of susceptible individuals can actually increase 
during periods of low transmission to the point of potentiating large outbreaks in ensuing 
years, particularly among older adults who are typically not the focus of vaccination and 
other disease control programs. As morbidity decreases and people have less personal 
experience with disease, perceived risk of the disease decreases, and the societal support of 
control and elimination efforts withers. Concomitantly, the cost of surveillance per case 
inflates because the infected populace becomes more isolated. Stakeholders, such as policy 
makers and citizens, also may have concerns at this stage that resources are being diverted 
                                                             
1 Invasive pneumococcal disease, invasive disease from Haemophilus influenzae type b, measles, influenza, 
rotaviral diarrhea, hepatitis A, hepatitis B, tetanus, pertussis, varicella, and diphtheria 
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from other primary care programs into overseeing cases of a disease that no longer 
represents a high morbidity in a particular region [3]. 
 China has an extensive system of hospitals, immunization clinics, and Centers for 
Disease Control (CDC) which work in concert to prevent and treat vaccine-preventable 
diseases. Since 2003, China has been rolling out a progressively comprehensive insurance 
scheme, and now 95% of Chinese have some form of medical insurance to cover some costs 
associated with treating diseases [4]. In contrast, immunizations, which are offered at 
immunization clinics, are not covered by insurance, and are either completely publically 
funded or require payment out-of-pocket. Immunization services in China fall under the 
purview of CDCs. The CDC network includes a national CDC, provincial-level CDCs 
(including those for the provincial-level municipalities Beijing, Tianjin, Shanghai, and 
Chongqing), and CDCs at districts at other lower-level administrative regions within 
provinces. Doctors trained in preventive medicine work at the CDCs to investigate 
outbreaks and evaluate disease control programs, such as immunization services [5]. 
 Some researchers have indicated that one obstacle in eliminating measles and 
controlling other infectious diseases in China is the rising number of internal migrants, 
referred to in this dissertation as the non-local population [6,7]. There are over 220 million 
migrants in China who do not have official residency papers, or hukou, which give a Chinese 
citizen access to local government entitlement programs, including education, health care 
services, and social security [8,9]. These migrants typically move from poorer and more 
rural areas in Western China to wealthier cities on the East Coast of China [9,10], where 
they may face societal discrimination [9]. Some studies have found that non-local children 
do have lower vaccination coverage [11–13], but research into differences in 
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immunological protection by residency show mixed results [14,15]. Moreover, most 
provinces in China have had two measles supplementary immunization activities for locals 
and non-locals in the past decade, in addition to offering free vaccines to all children within 
routine services. Therefore, there are not obvious relationships among residency status, 
measles vaccination, and measles infection; and, in particular, previous research on 
measles cases in China [7,16,17] has not adequately quantified the difference in measles 
incidence rate by residency status. 
 
Vaccination programs 
 The World Health Organization (WHO) recommends all immunization programs to 
include vaccinations against tuberculosis, hepatitis B, polio, diphtheria, tetanus, pertussis, 
Haemophilus influenzae type b (Hib) disease, pneumococcal disease, rotavirus, measles, 
rubella, and human papillomavirus (HPV) [18]. In its Expanded Program on Immunization 
(EPI), the government-funded program of routine immunization services, China 
incorporates a slightly different list of vaccines. Hepatitis A, meningococcal meningitis, 
Japanese encephalitis, and mumps vaccines are funded by the government in addition to 
the WHO-recommended list,  although China does not include Hib, pneumococcal, rotavirus, 
or HPV vaccines on the national EPI schedule [19]. Even so, many of these vaccines are 
available for children at immunization clinics, but the family of the child must pay out-of-
pocket for administration. 
 Proof of prior administration of EPI vaccines is required for school entry, and 
coverage of these vaccines is therefore typically high throughout China, and especially in 
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wealthier cities in Eastern China.  Even in Gansu province, a less wealthy province in 
Western China, 86% of infants were up-to-date with EPI vaccinations by 12 months [20]. 
 Because of their cost and because they are not required for school entry, non-EPI 
vaccines have lower coverage than EPI vaccines. In a survey of electronic vaccination 
records from Guangzhou, only about half of children were vaccinated against rotavirus by 5 
years of age [21]. A study from the Shanghai immunization information system found that, 
among children between the ages of 2 and 6, only 50.9% had received a Hib vaccine and a 
mere 11.4% had received a pneumococcal conjugate vaccine, and that both vaccines were 
typically delayed so as not to be co-administered with EPI vaccines [13]. 
 In this dissertation, I focus on two vaccine-preventable infections in order to better 
generalize the experience of vaccinations in China beyond one particular example. Measles 
vaccine is a free vaccine and has been on the China EPI  since 1978 [19]. Further, there has 
been tremendous attention placed on measles in China and worldwide for its elimination 
effort [22]. Conversely, the pneumococcal vaccine has only been more recently introduced 
to the Chinese market and it is prohibitively expensive for many Chinese. Although it has 
been listed on the EPI schedule of many countries, including those less developed than 
China [23], China has yet to publically fund this vaccine [24]. 
 
Measles 
Measles has already been eliminated in the Americas, and the other five regions of 
the World Health Organization (WHO) have planned to eliminate measles by 2020 [25]. 
Elimination is possible because of measles vaccination; before the invention of the measles 
vaccine, 90% of people would be infected by age 20, leading to 100 million cases and 6 
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million deaths each year [26]. As measles vaccination coverage has increased, measles 
morbidity and mortality has decreased. From 1990 to 2010, for instance, deaths worldwide 
from measles decreased from 631,200 to 125,400 [1]. 
China has put forward several goals to control measles. One of the first goals, to 
reduce measles incidence by 90% between 1965 and 1995 [7], was achieved when 
incidence declined from over 1,000 cases per 100,000 in the 1960s before vaccination to 
5.7 cases per 100,000 in the late 1990s [7]. Subsequent goals, to reduce measles incidence 
by 90% from 2000 to 2010 and to eliminate measles by 2012, a highly publicized WHO goal 
[27], were not reached: incidence decreased slowly from 6 cases per 100,000 in 2000 [28] 
to only 2.86 in 2010 [17]. Moreover, there has been a slight upswing in cases between 2011 
and 2014. There has not been a convincing explanation for China’s difficulty in eliminating 
measles, especially given that China has invested in both routine immunization services 
and supplementary immunization activities [17]. 
China approved its own measles vaccine strain in 1966, and has since used a 
domestically-produced vaccine as the first dose of measles vaccine [29]. A review of 70 
studies showed measles vaccine efficacy of 84.0% at 9 to 11 months of age and 92.5% at 12 
months of age or older [30]. Therefore, more than one dose of measles vaccine is necessary 
to ensure adequate herd immunity within a population, especially when the first dose is 
given at <12 months of age. Immunization clinics in Shanghai and Tianjin, China, currently 
provide 3 doses of measles-containing vaccine (MCV) for free to every child as part of its 
EPI: a measles-rubella combined vaccine (M1) is given to children at 8 months of age, and a 
measles-mumps-rubella combined vaccine (MMR) is given to children at 18-24 months of 
age (MMR1) and at 5 years of age (MMR2) [31]. Although most children in China are 
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eventually vaccinated against measles, we found in a previous study in Tianjin that less 
than 90% of children were vaccinated on-time [32], and another study from Zhejiang 
province found only 70.1% of children had a timely administration of the first dose of MCV 
[12]. Because the amount of vaccination delay in these circumstances is substantial, vaccine 
timeliness is a better indicator of population-level immunity than estimating coverage 
regardless of the timing [33]. 
 According to the WHO, the second dose of MCV can be given either in routine 
immunization services or in supplementary immunization activities (SIAs), which are mass 
immunization events within a defined geographical region over a short period of time and 
which were successful in eliminating measles in the Americas in the 1990s and early 2000s 
[34]. In catch-up SIAs, all children within a particular age group are vaccinated, typically 
regardless of their previous vaccination status. Follow-up SIAs then focus on the children 
born since the previous SIA [35]. Between 2004 and 2009, 25 of 31 province-level 
administrative regions in mainland China implemented catch-up SIAs, vaccinating 164 
million children [16]. In 2010, follow-up SIA delivered 102.3 million doses nationwide [36]. 
In Tianjin, the 2008 catch-up SIA distributed 1.3 million doses of measles vaccine to 
children between the ages of 8 months and 14 years; and the 2010 follow-up SIA targeted 
all children aged 8 months to 4 years, and 450,000 MCV doses were administered [37].  
 
Pneumococcal disease 
 Pneumococcus is responsible for a spectrum of disease, from otitis media to serious 
invasive disease, including pneumonia, meningitis, and septicemia [38]. Like measles, it can 
also be directly spread through airborne droplets, but the transmission dynamics and 
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epidemiology of pneumococcus are complex and less well characterized than a highly 
communicable disease such as measles. Pneumococcal disease is often preceded by 
asymptomatic colonization of pneumococcus in the nasopharyngeal tract [39]. A total of 90 
serotypes of pneumococcus have been discovered, and immunity is thought to be serotype 
specific [40]. In contrast to worldwide declines in measles mortality, mortality from 
invasive pneumococcal disease has remained relatively stable at over 900,000 deaths from 
1990 to 2010 [1]. 
Unlike measles, pneumococcus is not a nationally notifiable disease in China [41].  
Identification of pneumococcal cases in China faces some difficulty because its clinical 
presentation is similar to that of other infectious diseases, like Hib disease and 
meningococcal disease, and because common antibiotic overuse makes isolation of bacteria 
from patients difficult [42]. From a review of literature published on pneumococcus cases 
throughout China, Chen et al. estimated that in 2000 there were 384.45 cases of 
pneumococcal pneumonia per 100,000 children <5 years and 1.33 cases of pneumococcal 
meningitis per 100,000 children <5 years [43]. 
Two different pneumococcal vaccines are available at immunization clinics in China 
for a fee. The 23-valent pneumococcal polysaccharide vaccine (PPSV) can only be 
administered to children ≥2 years and it produced a T-cell independent response [40,44]. A 
7-valent pneumococcal conjugate vaccine (PCV) has been available since 2008 in China 
[24]. It protects against fewer serotypes and is substantially more expensive than PPSV 
($135 per dose of PCV compared to $24 per dose of PPSV), but it is more immunogenic and 
is licensed in China for infants as young as 6 weeks of age. 
Health behaviors 
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Anthropologist Mark Nichter distinguishes between passive acceptance of and 
active demand for vaccinations [45]. The populace attains high vaccination coverage only 
after the public health sector devotes intensive resources towards promoting a certain 
vaccine in the former scenario, whereas in the latter, a well-informed public perceives the 
need for vaccination and drives demand for immunization services. With no government 
funding currently for pneumococcal vaccination, it is unclear which of Nichter’s scenarios 
pneumococcal vaccination falls into. Understanding Chinese parents’ perceptions about 
both this non-EPI vaccine and the diseases it prevents is key to developing effective 
interventions to increase vaccine uptake. And, if pneumococcal vaccine is added to the EPI 
schedule, understanding parental attitudes towards it will be important for developing 
programs to increase people’s acceptance of the vaccine.  
 Vaccine decision-making can be explained by health behavior models like the Health 
Belief Model (HBM), which is one of the oldest [46] and most used [47] models to explain 
health behavior. It explains and predicts behavior by conceiving of health-related actions as 
an output of an individual’s perceptions of both a disease and an action related to that 
disease. These constructs specifically include people’s perceived susceptibility or 
vulnerability to the disease, their understanding of disease severity, a sense of the potential 
benefits of the action, and anticipated barriers or obstacles to performing that action [48].  
 The HBM has often been used to explain vaccination behaviors worldwide [46,49–
51]. In China, an HBM framework has explored dysentery vaccine need [52], influenza 
vaccination intent [53], and influenza vaccine uptake among healthcare workers [54]. 
Although these studies show the usefulness of HBM to describe vaccination behaviors in 
China, no previous study in China has compared and contrasted perceptions towards EPI 
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and non-EPI vaccines. It may be that people think differently about measles and 
pneumococcal vaccines, which have dissimilar payment mechanisms, which vary by length 
of time on the market, and for which people plausibly have assorted levels of experience.  
 Other health behavior models, such as the Theory of Planned Behavior and the 
Social Norms Theory, incorporate community-level behaviors, like social norms, into their 
predictions of individual-level behaviors. Here we can distinguish from the descriptive 
norm of vaccination, which is the perceived commonness or prevalence of vaccination in a 
community, from the subjective norm of vaccination [55,56], which is the perceived social 
pressure to perform or not perform this behavior [57]. Some researchers suggest that 
descriptive norms are better than subjective norms at predicting intent to perform a health 
behavior [56,58]. 
 
Multilevel models 
 Multilevel models, in which community-level factors are placed in models to predict 
individual-level outcomes, have become increasingly important in public health literature 
[59]. Vaccination itself offers multilevel protection: vaccines not only prevent disease in the 
individual, but also in an individual’s social contacts through herd immunity. Neighborhood 
social characteristics, such as urbanicity, race/class composition, and age structure, may 
influence an individual’s risk for disease or a parent’s attitudes towards vaccination 
through a variety of mechanisms. Neighborhoods describe an individual’s built and natural 
environment in which disease spreads and in which health care facilities provide 
preventive care. Neighborhoods’ differing demographic characteristics may differentially 
dispose an individual to disease. For instance, neighborhoods with more children may 
10 
 
foster the spread of infectious diseases commonly found in young children; places with 
many transient workers may see high incidence of diseases carried by migrants; and social 
norms within one community may value, or disapprove of, certain medical interventions, 
such as vaccination. 
 Previous studies have found some important links between neighborhood-level risk 
factors and immunization. A survey in the Netherlands in 2009 found community political 
preferences and socioeconomic condition to be linked to HPV uptake [60]. A study of 
Hawaiian kindergartners in 2002-2003 found that Census tract-level statistics, including 
education levels, urbanicity, and ethnic proportions, were significantly associated with up-
to-date immunizations [61]. 
 
Health registries 
 Data for parts of this dissertation come from electronic health record (EHR) systems. 
I have analyzed the epidemiology of measles cases from Tianjin in the National Infectious 
Disease Monitoring Information System (NIDMIS), and vaccination patterns from the 
Shanghai Immunization Program Information System (SIPIS). China has followed a similar 
path as the US, by first creating state- (or province-) based registries focused on particular 
conditions, such as notifiable diseases or vaccinations. Over time, the US has standardized 
some registries so that information from different states can be communicated to the 
Centers for Disease Control and Prevention (CDC), but by and large, these health registries 
in the US are discrete entities. This type of registry can be contrasted with many EHR 
systems in northern Europe, where registries, like cancer registries, prescription registries, 
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and cause-of-death registries, can be interlinked through a standard individual identifier 
[62].  
 Regardless of their complexity or ability to communicate with other systems, these 
registries have a number of common, important functions. Registries are a continuous 
repository of data which have been systematically collected. Researchers and public health 
officials can use registries to analyze data, with the focus on determining public health 
priorities, evaluating public health practices, and planning for future programs [63]. Highly 
functional registries not only benefit researchers at a central location but also staff at a 
particular health clinic—for example, by allowing for calculations of disease statistics 
within the clinic. This is an important incentive for participation even beyond any legal 
mandate to do so. 
Registries can be contrasted with the carefully delineated study populations of 
traditional public health studies. Though theoretically a census of the population within a 
defined geographical region, registries are dependent on both patients interfacing with 
health care professionals and the health care professionals, who need to transmit the data 
into a central database. As patients move out of the registry catchment area, there is 
attrition from the registry which is not always marked within the registry database. The 
information collected within a registry tends to be limited. Changes in how data are 
collected or what questions are asked can limit temporal comparisons. 
 
Tianjin and Shanghai 
 The People’s Republic of China comprises 33 province-level administrative regions. 
Beijing, Tianjin, Shanghai, and Chongqing are 4 directly-controlled municipalities, meaning 
12 
 
that they have the same political privileges as provinces, but are in geographically 
restricted areas. Though these municipalities contain populous, urban districts, adjacent 
suburban districts and rural counties also figure into the municipality’s administration. The 
3 municipalities in eastern China—Beijing, Tianjin, and Shanghai—are the wealthiest 
subdivisions in China, and are shown in Figure 1-1. In 2013, GDP per capita is 93,213 RMB 
(15,015 USD) in Beijing, 99,607 RMB in Tianjin (16,083 USD), and 90,092 RMB in Shanghai 
(14,547 USD) [64]. All three of substantial disparities between urban and rural populations; 
average disposable income in urban areas is over fifty two hundred dollars for all three 
municipalities, but rural net income is below thirty two hundred dollars. These cities also 
each have substantial non-local populations. Of the 21.1 million residents in Beijing, 8.0 
million are non-locals; 4.7 million of the 14.7 million people in Tianjin are non-locals; and 
Shanghai’s 24.1 residents include 9.8 million non-locals [64]. 
 
Aims 
 Overall, this dissertation seeks to answer the questions “What are the differences 
between locals and non-locals in disease incidence and vaccination outcomes in China?” 
and “What are the similarities and differences between measles and pneumococcal 
vaccination programs in China?” I respond to these questions in Chapters 2 through 4. In 
Chapter 2, we use data from the Tianjin notifiable disease registry to characterize temporal 
trends in measles incidence by residency (non-local versus local) and to evaluate the 
impact of SIAs on measles incidence. Chapter 3 explores vaccination outcomes in terms of 
timely M1 and MMR1 administration as well as uptake of PCV and PPSV. Specifically, we 
estimate the proportion of children in Shanghai with these vaccination outcomes, compare 
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vaccination outcomes in non-locals and locals, and assess the impact of township-level 
characteristics on vaccination outcomes. In Chapter 4, we compare perceptions of pediatric 
measles and pneumococcal vaccinations among parents in Shanghai, and we characterize 
the associations between HBM constructs, demographic characteristics, and perceived 
vaccine necessity, by disease.  
14 
 
 
 
 
Figure 1-1. Locations of Beijing, Tianjin, and Shanghai, three province-level municipalities 
in Eastern China. 
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CHAPTER 2 
The impact of Supplementary Immunization Activities on the epidemiology of 
measles in Tianjin, China 
 
ABSTRACT 
Background. Non-locals, or migrants from rural areas to wealthier cities, are often blamed 
for China’s difficulty in controlling measles, particularly as China seeks to eliminate 
measles through supplementary immunization activities (SIAs). Here, we characterize 
temporal trends in measles incidence by residency (non-local versus local) and evaluate 
the impact of SIAs on measles incidence. 
Methods. We tabulated daily counts of laboratory-confirmed measles cases for both locals 
and non-locals. These two datasets were then combined into a single dataset where each 
day had two observations. We conducted multivariable Poisson regression using 
generalized estimating equations with an exchangeable correlation structure to account for 
each day having two counts. 
Results. From 2005 through 2013, there were 5,730 laboratory-confirmed cases of 
measles in Tianjin. A substantial disparity in the rate of measles between non-locals and 
locals is observed before the 2008 SIA (RR: 2.91, 95% CI: 2.56, 3.31), but this attenuates to 
non-locals having a rate of measles only 1.39 times higher between the 2008 and 2010 SIAs 
compared to locals (95% CI: 1.17, 1.66). There was no significant difference in the rate of 
measles between non-locals and locals after the 2010 SIA. 
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Discussion. Although we observed a reduction in measles disparities between locals and 
non-locals over time, persistent efforts will be needed to keep measles incidence low 
among non-locals in urban settings because of the continual migration of people in China. 
 
INTRODUCTION 
Measles was officially eliminated in the Americas in 2002 [1], and the other five 
regions of the World Health Organization (WHO) are slated for measles elimination by 
2020 [2]. This remarkable success in control of a highly infectious disease has been made 
possible through the global adoption of measles vaccination. Prior to the advent of the 
measles vaccine, 90% of people were infected by age 20, resulting in 100 million cases and 
6 million deaths each year [3]. As vaccination coverage has increased, the number of deaths 
from measles has decreased from 631,200 in 1990 to 125,400 in 2010 [4]. 
The Chinese government is committed to measles elimination and although the 
country did not meet its original elimination target of 2012, they have made steady 
progress in measles control. The initial goal to reduce measles incidence by 90% between 
1965 and 1995 [5] was met with the decline from over 1,000 cases per 100,000 in the 
1960s prior to measles vaccine availability to 5.7 cases per 100,000 in the late 1990s [5]. 
Subsequent goals, to reduce measles incidence by 90% from 2000 to 2010 and to eliminate 
measles by 2012 [6], were not realized as disease incidence gradually decreased from 6 
cases per 100,000 in 2000 [7] to only 2.86 in 2010 [8], followed by a slight upswing in 
cases between 2011 and 2014. The exact reason(s) for China’s inability to achieve 
sustained reductions in measles leading to elimination are not entirely clear, especially 
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given that China has invested heavily in both routine immunization services and repeated 
national supplementary immunization activities [8]. 
 China introduced its own measles-containing vaccine (MCV) to market in 1966 [9], 
which was subsequently integrated in 1978 into the Expanded Program on Immunization 
(EPI), a government-funded initiative to provide select vaccine free of charge to all children 
[10]. Although the national EPI schedule in China recommends two doses of MCV [10], the 
schedule in Tianjin and some other places differs by recommending an additional MCV 
dose. Currently in Tianjin, MCV1 is administered as a measles-rubella vaccine given at 8 
months; MCV2, a measles-mumps-rubella vaccine (MMR) is administered at 18 to 24 
months of age; and MCV3 is a second dose of MMR given at 5 years of age [10]. This third 
dose is important because the first dose of MCV is not as immunogenic when administered 
to children under 1 year of age [11]. However, the cost of giving what is generally 
considered an additional “throw away dose” of MCV in the first year of life is outweighed by 
the perceived benefits of insuring infants are immunized to measles given the high burden 
of disease in this age group in China [8]. 
 According to the WHO, MCV2 can be given either as part of routine immunization 
services or in supplementary immunization activities (SIAs), which are mass immunization 
events within a defined geographical region delivered over a short period of time. The 
strategic use of periodic SIAs were successful in eliminating measles in the Americas in the 
1990s and early 2000s [1]. In catch-up SIAs, all children within a particular age group are 
vaccinated, typically regardless of their previous vaccination status. Follow-up SIAs then 
focus on mass vaccination of children born since the previous SIA [12]. Between 2004 and 
2009, 25 of 31 province-level administrative regions in mainland China implemented 
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catch-up SIAs, collectively vaccinating 164 million children [13]. In 2010, follow-up SIA 
delivered 102.3 million doses nationwide within the same time period [14]. In Tianjin, the 
2008 catch-up SIA administered 1.3 million doses of measles vaccine to children between 
the ages of 8 months and 14 years; and the 2010 follow-up SIA, which targeted all children 
aged 8 months to 4 years, resulted in the administration of 450,000 MCV doses [15].  
 The epidemiology of measles in China has been characterized by periodic regional 
and national outbreaks. Many researchers and Chinese public health officials suggest that 
these outbreaks are potentiated by the country’s highly mobile population [5,8,16], who 
are moving from poorer and more rural areas to wealthier cities [17,18]. These internal 
migrants are sometimes called the floating population although we refer to them as non-
locals in this paper in order to distinguish their residency status from “locals.” There are 
over 260 million of these internal migrants in China who do not have official residency 
papers, or hukou, which accord Chinese citizens access to local government entitlement 
programs, including education, social security, and some health care services [18,19]. Even 
though non-local children are offered EPI vaccines for-free, just like local children, they 
nonetheless have been shown in some studies to have lower coverage of EPI vaccines than 
locals [20], which public health officials have attributed, at least in part, to the difficulties 
government immunization services encounter in trying to locate and identify children who 
have newly relocated to a particular area [8].  
 China has made a large financial investment in both funding routine measles 
immunization services and delivering hundreds of millions of doses of measles vaccine to 
children through SIAs. Despite these efforts, there has been a periodic resurgence of 
measles in recent years resulting in China’s failure to meet its own goal of disease 
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elimination by 2012. Lower vaccination coverage among non-locals could be an important 
contributing factor to sustained measles transmission and outbreaks although MCV is 
offered to all children in routine immunization services. Moreover, within the past decade 
the majority of provinces in China have had 2 SIAs, which mostly have targeted all children 
in the province between 8 months and 14 years of age [13]. More research is needed to 
fully characterize the changing epidemiology of measles in China and to quantify the 
difference in measles incidence by residency status, since previous research on measles 
cases in China [5,8,13] has not adequately addressed this question. In this paper, we use 
data from the Tianjin notifiable disease registry to characterize temporal trends in measles 
incidence by residency (non-local versus local) and to evaluate the impact of SIAs on 
measles incidence. 
 
MATERIALS AND METHODS 
Study population 
 This study used data from Tianjin, a municipality 100 km away from Beijing. It is 
one of the wealthiest subdivisions in China, with a GDP per capita of 99,607 RMB ($16,083) 
in 2013. There has been substantial migration into this city from outside areas: in 2014, 4.7 
million of the 14.7 million people in Tianjin were non-locals [21]. Though Tianjin does 
contain populous, urban districts, adjacent suburban districts and rural counties also figure 
into the municipality’s administration. The health infrastructure in Tianjin includes both a 
municipality-wide Center for Disease Control and Prevention (CDC) with jurisdiction over 
the entire municipality as well as district-level CDCs. 
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 Measles is a notifiable infectious disease in China [22], and suspected cases at 
hospitals are reported into the National Infectious Disease Monitoring Information System 
(NIDMIS). These cases are investigated by staff from district-level CDCs. NIDMIS includes 
demographic information for each case (birth date, sex, district of residence, residency), 
vaccination status (unknown, ≥1 dose, or 0 doses), and date of onset of fever. We limited 
our analysis to cases with laboratory confirmation because of limited information on 
clinically-confirmed cases in the database. Laboratory-confirmed cases are required to 
have a positive IgM result reported from serum or other body fluid or to include report of 
wild-type measles virus isolated by RT-PCR [23]. 
 
Derived variables 
 The two municipal-wide SIAs in Tianjin occurred in December 2008 and in 
September 2010. We grouped cases into 3 time periods, depending on when their reported 
date of onset of fever was relative to the SIAs. Fevers starting on January 1, 2005, through 
December 4, 2008, were considered “before the 2008 SIA”; cases whose fever started on 
December 5, 2008 through September 20, 2010, happened “between the 2008 and 2010 
SIAs”; and “after the 2010 SIA” includes all cases who had fevers starting on September 21, 
2010, through December 31, 2013.  
 We distinguished district-level administrative regions by urbanicity, with urban 
areas being home to more high-income industries [24] and having better access to public 
services [25] than suburban and rural areas. The 7 urban districts in Tianjin are Heping, 
Hedong, Hexi, Nankai, Hebei, Hongqiao, and Binhai New Area; 4 districts are categorized as 
27 
 
suburban—Jinnan, Dongli, Xiqing, and Beichen; and 2 districts (Baodi and Wuqing) as well 
as 3 counties (Ji, Jinghai, and Ninghe) are considered rural. 
 
Statistical analysis 
 The distribution of cases was recorded by sex, urbanicity, residency, vaccination 
status, and time period. The rate of measles was plotted over time, with the rate calculated 
by dividing case counts from annual population figures which were available from the 
China Statistical Yearbook. Separate population figures were available each year for both 
locals and non-locals. 
We first did an exploratory analysis of the time series of measles. Monthly case 
counts from January 1, 2005, to December 31, 2015, were tabulated for the total population, 
and separately by residency and age group (<8 months, 8 months to <15 years, 15 years 
and above). Subsequently, we used observed monthly case counts from January 2005 to 
November 2008 to forecast monthly case counts from January 2009 to December 2015 
using exponential smoothing with additive error, trend, and seasonal components. 
To make formal inferences about rates in locals and non-locals, we calculated daily 
case counts separately for these two groups. These two datasets were then combined into a 
single dataset where each day had two observations, one for locals and the other for non-
locals. We conducted multivariable Poisson regression using generalized estimating 
equations with robust variation estimation and with an exchangeable correlation structure 
to account for each day having two counts. The natural log of the population by residency 
was added to the model as an offset to obtain rates. The main predictors in this model were 
residency, time period, and an interaction between residency and time period. This model 
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also controlled for a lag 1 autoregressive term (AR1) and seasonality of measles. Measles 
seasonality was the seasonal component of a daily time series, which was decomposed into 
trend, seasonal, and remainder components. 
 The data were analyzed in R [26], and we used the STL procedure [27] and the 
packages forecast [28] and geepack [29]. 
 
Ethics statement 
 This study was limited to analyses of de-identified cases. Because it fell under 
standard public health surveillance activities, the University of Michigan Institutional 
Review Board determined that the study was exempt from regulation. 
 
RESULTS 
 From Jan 1, 2005, through December 31, 2013, there were a total of 5,730 
laboratory-confirmed cases of measles reported in Tianjin, China. Slightly more cases were 
males (57.8%) than females, a majority (72.9%) were locals, and there was an even 
distribution of cases from urban (31.3%), suburban (37.4%) and rural (31.3%) districts. 
Most of the cases (65.9%) occurred before the 2008 SIA, 28.2% of all cases occurred in the 
21 months between the two SIAs, and only 6.0% after the second municipality-wide SIA. 
 Table 2-1 shows the distribution of demographic and vaccination characteristics 
overall and by residency. There was a bimodal distribution of cases by age, with most cases 
occurring either in children under 5 years of age, or adults over 15 years of age, the 
majority of whom were under 40 years of age. Compared to locals, non-local cases were 
more likely to be younger than 30 years of age. Additionally, most cases (54.5%) aged 8 
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months to <15 years were unvaccinated and more non-locals (60.3%) than locals (50.6%) 
in this age category had not received a measles vaccine. 
 The count and frequency of demographic characteristics relative to the SIAs is 
shown in Table 2-2. There was a shift in the geography of cases over time; before the 2008 
SIA, most cases occurred in suburban (41.7%) and rural areas (33.3%), but after the 2010 
SIA, only 27.1% and 15.2% occurred in these areas, respectively. Although fewer childhood 
cases had been vaccinated against measles between the 2008 and 2010 SIAs (22.3%) 
compared to before the 2008 SIA (39.7%), there was not an appreciable difference in the 
proportion of vaccinated children after the 2010 SIA (34.0%) compared to before the 2008 
SIA. 
Figure 2-1 shows a decline in the rate of measles over time, and in particular, the 
disparity between the rates of measles in non-locals and locals disappears by 2010. In 
Figure 2-2, a similar seasonal pattern is seen for both locals and non-locals. There is a 
difference in the configuration of measles counts over time across different age groups. For 
infants <8 months of age and persons ≥15 years of age, who were not vaccinated in either 
SIA, there was a sharp increase in the number of cases in 2010, compared to 2009, whereas 
for children from 8 months through 14 years of age, this increase was in line with predicted 
values from the time series forecast. From 2011 on, there were few cases of measles, 
although a slight increase was seen in 2013. 
Results from the multivariable regression are presented in Table 2-3. A substantial 
disparity in the rate of measles between non-locals and locals is observed before the SIAs 
(RR: 2.91, 95% CI: 2.56, 3.31), but this attenuates to non-locals having a rate of measles 
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1.39 times higher during the SIAs compared to locals (95% CI: 1.17, 1.66). There was no 
significant difference in the rate of measles between non-locals and locals after the SIAs. 
 
DISCUSSION 
SIAs have been an important tool used worldwide to progress towards disease 
elimination in a cost-effective manner [1,30,31]. We found a substantial reduction in the 
number of measles cases in Tianjin, China following implementation of two municipality-
wide SIAs. In addition to dramatically reducing the overall number of measles cases, the 
reductions were accompanied by a diminishing gap in measles rates between non-locals 
and locals, which eventually disappeared completely after the 2010 SIA. SIAs have been 
shown to be key in eliminating measles in the Americas [1], and reducing incidence of 
disease in Eastern Europe [30]. A study of 15 province-wide SIAs taking place in China 
during 2004-2008 found that there was on average an 88.1% decrease in measles 
incidence the year after an SIA compared to the average rate in the preceding five years 
[13]. Even in Guangxi, a less developed province in China, non-synchronous SIAs taking 
place in high-incidence counties over 8 years reduced measles incidence 84.7% in the 
entire province during this time period [32]. Especially for countries and regions with 
weaker capacity to reliably deliver vaccines in routine immunization services, SIAs are a 
cost-effective method to distribute the second dose of measles vaccines [31].  
 However, there are well recognized disadvantages to SIAs, including the future 
accumulation of susceptible children who were too young to have been vaccinated after the 
SIA. In our study, we observed a large increase in measles cases among young infants and 
young adults in 2010, two years after the first, municipality-wide SIA. Similarly, three years 
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after a major SIA in Xinjiang, China, a large-scale outbreak occurred, predominantly in 
children born after the SIA [13]. Characterization of measles incidence for several years 
after an SIA is, therefore, important in order to not yield to the frequent common practice 
of over-ascribing success in disease control to an SIA, which instead of resulting in 
sustained reductions in measles incidence may instead shift the burden of disease to later 
birth cohorts or foster development of a biennial cycle of heightened measles transmission. 
SIAs also tend to be confined in their geographic impact, in that they typically target 
people residing within a defined city, county, or province, which limits their effectiveness 
in controlling spread of disease among persons who migrate to this region after the SIA 
occurred. China’s switch from utilizing staggered SIAs occurring at different times and 
regions throughout the year before 2009 to a single, synchronized national event in 2010 
may be one explanation for why a local/non-local disparity in measles incidence persisted 
in the two years after the first SIA, but not after the second SIA. Numerous studies in China 
have suggested that migrants are a cause of high measles incidence [5,13,32], although it is 
a shortcoming that none of these previous studies quantified the rate of disease in non-
locals or the disparity in rates between locals and non-locals. Moreover, beyond directly 
transmitting disease, unvaccinated migrants increase the pool of susceptible individuals in 
a population, which theoretically leads to a larger peak number of measles cases every 
second year [33,34]. As increased numbers of migrants move into Tianjin, NIDMIS could be 
used to not just measure the seasonality and incidence of measles cases but also identify 
high risk groups and forecast future epidemiological scenarios. 
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Strengths and Limitations 
Because we had access to a disease information from a population-based registry 
and population information from the China Statistics Yearbook, we were able to compare 
the burden of disease between locals and non-locals, controlling for different population 
sizes. As China continues to focus significant resources on the elimination of endemic 
transmission of measles, identifying high-risk groups will likely become more logistically 
difficult and resource intensive[35]. Establishing linkages between NIDMIS and other 
databases, like immunization registries, population statistical databases, and hospital 
records, could increase the usefulness of NIDMIS to identify higher risk, susceptible 
populations and provide data to research correlates of disease. Importantly, giving 
hospitals access to some information within a limited geographic area could provide useful 
knowledge about their catchment area and increase their motivation to provide timely, 
comprehensive reports of disease [36]. 
 This study uses laboratory-confirmed cases, and most measles cases in China were 
laboratory-confirmed by 2009 [8]. Prior to this, many cases were only clinically-confirmed 
(i.e. based on clinical presentation without supporting laboratory evidence), but because of 
the clinical similarity between measles and other febrile rash illnesses, like rubella, 
clinically-confirmed cases are subject to misclassification [37]. Moreover, there is no 
evidence to suggest that residency status, our main predictor, was related in any way to the 
confirmation method for measles. This lack of clinically-confirmed cases, predominantly 
from before 2009, could, however, attenuate our estimate of the impact of SIAs on measles 
incidence. 
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 An additional limitation is the validity of population figures, particularly for non-
locals. Our data on population size came from the China Statistical Yearbook, but China has 
changed how it estimates the size of the non-local population over time [38]. However, it is 
widely reported that population growth in Chinese cities over the past decade is primarily 
driven by migration and not through natural growth [39], which is what we observe in the 
population figures used in this study. 
 This study estimates the impact of SIAs by comparing measles incidence before and 
after the intervention, but a number of other conditions could affect incidence, including 
improved routine immunization services, which could have improved in targeting recent 
migrants. For example, Tianjin has introduced a program in recent years which pays 
immunization clinic doctors to find migrant children and enroll them at the clinic. 
 
Conclusions 
 A time-series analysis of reported measles cases in Tianjin, China from January 1, 
2005, to December 31, 2013, revealed a reduction in measles disparities between locals 
and non-locals, particularly after the occurrence of two municipality-wide SIAs. Because of 
the ongoing and significant internal migration of people in China, sustained efforts will be 
needed to keep measles incidence low among non-locals in urban settings: SIAs on a 
supraprovincial scale can reach future migrants to cities, mop-up SIAs can specifically 
target new arrivals to an area, and routine immunization services can be improved to 
better serve new arrivals. During the elimination period, dissemination of information from 
disease registries will be an important part of characterizing disease in subpopulations and 
evaluating control efforts. 
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Figure 2-1. Monthly rate of measles in Tianjin, China, in the total population and by residency. Inset 
includes data from 2011 through 2013 on a shorter axis. 
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Figure 2-2. Modelled (grey line) and observed (red line) cases of measles in Tianjin, China. Black arrows indicate the timing of 
supplementary immunization activities (SIAs).   
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Table 2-1. Demographic characteristics of measles cases in Tianjin, China, from 2005 through 2013. 
 
  
Residencya 
 
Overall Local Non-local 
 
Count (%) Count (%) Count (%) 
Overall 5,730 (100%) 4,178 (100%) 1,514 (100%) 
Sex 
        Male 3,313 (57.8%) 2,396 (57.3%) 894 (59.0%)
     Female 2,417 (42.2%) 1,782 (42.7%) 620 (41.0%) 
Urbanicity    
     Urban 1,796 (31.3%) 1,448 (34.7%) 331 (21.9%) 
     Suburban 2,141 (37.4%) 1,159 (27.7%) 968 (63.9%) 
     Rural 1,793 (31.3%) 1,571 (37.6%) 215 (14.2%) 
Age 
        <8 months 968 (16.9%) 762 (18.2%) 191 (12.6%)
     8 months to <5 years 975 (17.0%) 556 (13.3%) 410 (27.1%) 
     5 to <15 years 397 (6.9%) 239 (5.7%) 157 (10.4%) 
     15 to <30 years 1,793 (31.3%) 1,225 (29.3%) 560 (37.0%) 
     30 years and above 1,597 (27.9%) 1,396 (33.4%) 196 (13.0%) 
Time period 
        Before the 2008 SIA 3,774 (65.9%) 2,687 (64.3%) 1,049 (69.3%)
     Between the SIAs 1,613 (28.2%) 1,254 (30.0%) 359 (23.7%) 
     After the 2010 SIA 343 (6.0%) 237 (5.7%) 106 (7.0%) 
Vaccination statusb 
        0 doses 749 (54.5%) 402 (50.6%) 342 (60.3%)
     ≥1 dose 500 (36.4%) 347 (43.7%) 153 (27.0%) 
     Unknown 123 (9.0%) 46 (5.8%) 72 (12.7%) 
a 38 children with unknown residency status are excluded in these calculations. 
b For children aged 8 months to <15 years. 
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Table 2-2. Distribution of measles cases from Tianjin, from 2005 through 2013, by timing relative 
to Supplementary Immunization Activities (SIAs). 
 
 
Before 2008 SIA Between SIAs After 2010 SIA 
 
Count (%) Count (%) Count (%) 
Overall 3,774 (100%) 1,613 (100%) 343 (100%) 
Sex 
        Male 2,139 (56.7%) 984 (61.0%) 190 (55.4%)
     Female 1,635 (43.3%) 629 (39.0%) 153 (44.6%) 
Residency 
        Local 2,687 (71.2%) 1,254 (77.7%) 237 (69.1%)
     Non-local 1,049 (27.8%) 359 (22.3%) 106 (30.9%) 
Urbanicity 
        Urban 942 (25.0%) 656 (40.7%) 198 (57.7%)
     Suburban 1,575 (41.7%) 473 (29.3%) 93 (27.1%) 
     Rural 1,257 (33.3%) 484 (30.0%) 52 (15.2%) 
Age 
        <8 months 513 (13.6%) 392 (24.3%) 63 (18.4%)
     8 months to <5 years 706 (18.7%) 229 (14.2%) 40 (11.7%) 
     5 to <15 years 374 (9.9%) 13 (0.8%) 10 (2.9%) 
     15 to <30 years 1,261 (33.4%) 455 (28.2%) 77 (22.5%) 
     30 years and above 920 (24.4%) 524 (32.5%) 153 (44.6%) 
Vaccination statusa 
        0 doses 536 (49.6%) 181 (74.8%) 32 (64.0%)
     ≥1 dose 429 (39.7%) 54 (22.3%) 17 (34.0%) 
     Unknown 115 (10.7%) 7 (2.9%) 1 (2.0%) 
a For children aged 8 months to <15 years. 
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Table 2-3. Rate ratio estimates for measles by residency and timing relative to Supplementary 
Immunization Activities (SIAs). 
 
 Rate Ratio (95% CI) 
Non-local vs local  
     Before 2008 SIA 2.91 (2.56, 3.31) 
     Between SIAs 1.39 (1.17, 1.66) 
     After 2010 SIA 0.96 (0.76, 1.22) 
For Locals 
      Between SIAs vs before 2008 SIA 0.80 (0.69, 0.92)
     After 2010 SIA vs before 2008 SIA 0.17 (0.13, 0.21) 
For Non-locals 
      Between SIAs vs before 2008 SIA 0.48 (0.39, 0.59)
     After 2010 SIA vs before 2008 SIA 0.33 (0.25, 0.43) 
Poisson regression model using Generalized Estimating Equations controlled for seasonality, count 
of measles in the previous day, residency, and SIA time points. 
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CHAPTER 3 
Measles and pneumococcal immunization of Shanghai children: Assessing timeliness 
and predictors for vaccination 
 
ABSTRACT 
 
Background. Measles and pneumococcal vaccines are important tools to reduce morbidity 
and mortality in Chinese children, but delayed measles vaccination is a recognized problem 
in China and uptake of pneumococcal vaccines is limited by expense. Additionally, 
immunization services in large cities in China have difficulty reaching non-locals, migrants 
coming from outside the city. This study has three aims: to estimate the proportion of 
children in Shanghai with timely measles vaccinations and with the two different 
pneumococcal vaccinations; to compare vaccination outcomes in non-locals and locals; and 
to assess the impact of township-level characteristics on vaccination outcomes. 
Methods. Individual-level data from a cohort in the Shanghai Immunization Program 
Information System were linked to township-level data from the 2010 China Census. We 
used a generalized estimating equations framework with logistic regression models to 
assess individual- and township-level predictors of vaccination outcomes. 
Results. Non-locals had lower vaccination levels than locals. Non-locals had 0.44 times the 
odds of timely M1 (95% 0.42, 0.47), 0.27 times the odds of timely MMR1 (95% CI: 0.25, 
0.30), 0.36 times the odds of PCV1 by 8 months of age (95% CI: 0.31, 0.41), and 0.73 times 
the odds of PCV1 by 4 years of age (95% CI: 0.67, 0.80), compared to locals. For local 
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children born in 2007, a higher proportion of non-locals in the township was associated 
with less timely measles vaccinations but greater odds of pneumococcal vaccination. 
Discussion. Untimely measles vaccination and extremely low uptake of pneumococcal 
vaccination impede successful control of these infectious diseases in Shanghai. Because 
non-locals have worse outcomes than locals, they should be especially targeted for 
vaccination, and immunization information systems can track the progress in eliminating 
disparities. 
 
INTRODUCTION 
Measles and pneumococcal pneumonia followed only TB and malaria as the leading 
causes of infectious disease mortality worldwide in 1990 [1]. In the ensuing two decades, 
annual mortality from invasive pneumococcal disease (IPD), which comprises pneumonia, 
meningitis, and septicemia, has remained relatively stable at over 900,000 deaths in 
contrast to the substantial decrease in measles mortality, from 631,200 deaths in 1990 to 
125,400 deaths in 2010 [1]. Although the global epidemiology of these two vaccine 
preventable diseases are markedly different [2], the World Health Organization (WHO) 
recommends inclusion of vaccines for both diseases in all countries’ national immunization 
programs [3], and they would likely be two of the largest sources of infectious disease 
mortality worldwide in young children if it were not for vaccination programs. 
 China first approved the use of a measles vaccine in 1966 [4]. Because measles is so 
infectious and the measles vaccination is known to be less effective at younger ages [5], 
multiple doses of vaccine are necessary to ensure adequate herd immunity, especially 
when the first dose is given at <12 months of age [6]. In Shanghai, 3 doses of measles 
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vaccine are provided for free to every child as part of the government-funded Expanded 
Program on Immunization (EPI): a measles-rubella combined vaccine (M1) is administered 
to children at 8 months of age, and a measles-mumps-rubella combined vaccine (MMR) is 
given to children at 18-24 months of age (MMR1) and again at 5 years of age (MMR2) [7]. 
As a result of increasing measles vaccine coverage, measles incidence in China has declined 
from over 1,000 cases per 100,000 in the 1960s to 5.7 cases per 100,000 in the late 1990s 
[8]. Although China has mobilized to eliminate measles [9], it did not reach a goal of 
elimination by 2012, which was pushed back to 2020 [10,11]. Difficulty in controlling 
measles has been explained by increased numbers of migrants in China [8,12], as well as 
untimely measles vaccination. Although most children in China are eventually vaccinated 
against measles, previous studies have found that less than 90% of children have a timely 
administration of M1 [13,14]. With such substantial delay in vaccination, vaccine timeliness 
is a better indicator of population-level immunity than estimates of coverage that do not 
consider timing [15]. 
 In contrast to measles vaccines, pneumococcal vaccines (PVs) have only recently 
been introduced into China [16]. Two PVs are available at immunization clinics for a fee: 
the 23-valent pneumococcal polysaccharide vaccine (PPSV) since 1996 and the 7-valent 
pneumococcal conjugate vaccine (PCV) since 2008 [16]. Although PCV (135 USD/dose) is 
more expensive than PPSV (24 USD/dose), it is more immunogenic, and can be 
administered to children as young as 6 weeks, compared to PPSV which is only available 
for children ≥2 years [17]. Coverage of PVs is still relatively low in China [18], and 
promoting their dissemination does not appear to be a government priority [16], even 
though the vaccine could reduce the substantial burden of pneumococcal disease among 
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children in China. Chen et al. estimated that in 2000 there were 384.45 cases of 
pneumococcal pneumonia per 100,000 children <5 years and 1.33 cases of pneumococcal 
meningitis per 100,000 children <5 years [19]. 
 Several studies have shown that vaccination coverage is lower in non-locals, 
migrants from rural to urban areas, than locals, including coverage for pneumococcus and 
measles [18,20,13]. Of the 23 million residents in Shanghai, 9 million are non-locals who do 
not have the official residency papers, or hukou, which give a Chinese citizen access to some 
social welfare programs [21]. Children are, however, offered EPI vaccines for-free in China 
regardless of their residency status. 
 Non-locals often cluster together in neighborhoods [22], and this demographic 
clustering, along with other social characteristics associated with neighborhoods, could 
influence an individual’s attitudes towards vaccination through a variety of mechanisms. 
Neighborhoods represent the environment in which disease spreads and in which health 
care facilities provide preventive care. For instance, neighborhoods with more children 
may more frequently foster the spread of infectious diseases commonly found in young 
children; places with many transient workers may experience a higher incidence of 
diseases carried in by the migrants; and a community’s social norms, which are influenced 
by the demographic structure of that community, may value, or alternatively, disapprove of 
vaccination. Previous studies in the Netherlands [23] and in Hawaii [24] have found some 
important links between neighborhood-level risk factors, such as socioeconomic condition 
and racial distribution, and immunization status. In Shanghai townships, a neighborhood 
administrative division with over 100,000 people on average, not only have distinguishing 
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demographic characteristics but also have a shared experience of immunization services 
because people within a township attend the same immunization clinic. 
 The influence of township-level characteristic on vaccination characteristics has not 
been well-studied in China, and quantifying vaccination disparities between non-locals and 
locals within the context of the township where they actually reside is important in 
identifying pockets of susceptible populations and in evaluating whether immunization 
programs are equitably reaching diverse groups of people. Moreover, programs for 
different vaccinations are not likely to be equally successful, particularly for immunizations 
which have varying levels of governmental priority, national attention, and payment 
methods, as do the measles and pneumococcal vaccines. This study explores vaccination 
outcomes in terms of timely M1 and MMR1 administration as well as uptake of PCV and 
PPSV at milestone ages. Specifically, we estimate the proportion of children in Shanghai 
with these vaccination outcomes, compare vaccination outcomes between non-locals and 
locals, and assess the impact of township-level characteristics on vaccination outcomes. 
 
MATERIALS AND METHODS 
Study population 
 We used a single-stage cluster design to explore pediatric vaccination outcomes in 
Shanghai. Townships were selected by a probability proportionate to size (PPS) systematic 
selection procedure using population of children 0 to 14 years of age from the China 2010 
Census as the population size. In each selected township, we sampled every child born 
between January 1, 2000, and July 4, 2014. From a preliminary analysis of older data, we 
determined that 24 clusters were needed to discriminate between proportions of 92.4% 
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and 79.5%, the estimated values of MMR timeliness for locals and non-locals, respectively, 
given an intracluster correlation coefficient of 0.133. Figure 3-1 shows the location of the 
selected townships in Shanghai. 
 Because each vaccination outcome that we examined involves a different age group, 
our analysis uses 4 pools of children drawn from this first sample. For timely M1, we 
included children over 8 months of age, and excluded children with no M1 record given 
that measles vaccination coverage is very high in China [13,25], and no recorded measles 
vaccination could be indicative of attrition from the dataset or a contraindication to 
vaccination. Similarly, for timely MMR1, all children over 18 months of age who had a 
record of MMR1 administration were included. In examining PCV1 receipt by 8 months of 
age, we limited the analysis to children at least 8 months of age who were born in 2008 or 
after because the vaccine was not released in China until that year. For PV by 4 years of age, 
we included all children over 4 years of age, and stratified analyses based on whether they 
had received PCV compared to no PV or whether they had received PPSV compared to no 
PV.  
 
Data sources 
 This study combines individual-level data from a cohort in the Shanghai 
Immunization Program Information System (SIPIS) and township-level data from the 2010 
China Census. SIPIS includes information on children’s birthdate, sex, residency status 
(local vs non-local), the township immunization clinic where they received their latest 
vaccination, and dates of any vaccinations. Urbanicity was defined by the location of the 
township; Huangpu, Xuhui, Changning, Jing'an, Putuo, Zhabei, Hongkou, and Yangpu 
50 
 
comprise the urban districts; and the suburban districts are Minhang, Baoshan, Jiading, 
Pudong, Jinshan, Songjiang, Qingpu, Fengxian, and Chongming. 
 Timely M1 was defined as a measles vaccine or measles-rubella vaccine 
administered when the child was between 8 and 9 months of age, and MMR1 was 
considered timely if administered when the child was between 18 and 24 months of age. 
Vaccinations after these ages were considered untimely. The outcome, PCV1 by 8 months of 
age, compares children who had a dose administered by 8 months of age to children with 
no PCV by 8 months. Finally, PV by 4 years of age divides children older than 4 years of age 
into 3 outcome categories: those with no PV before 4 years, those with PCV administered 
before 4 years, and those with PPSV administered before 4 years. 
 The China 2010 Census provided information about township residency 
composition, and child dependency ratio (CDR). The township residency composition was 
derived from the proportion of non-locals living in the township, i.e. one minus the 
proportion of the total population of registered permanent residents in the total resident 
population of the township. The child dependency ratio (CDR) was calculated as the total 
population between the ages of 0 to 14 years divided by the total population between the 
ages of 15 and 65, multiplied by 100. In the multivariable regressions, the township 
residency composition was categorized based on which residency group, local or non-local, 
formed the majority of the population. The CDR was dichotomized at the median. 
 
Statistical analysis 
 Frequencies and proportions were calculated for each of the individual-level 
explanatory and outcome variables, and these proportions were compared by residency 
 51 
 
status. The mean and median were used to describe the distribution of the township-level 
variables before they were categorized. 
For each model, we fit a multilevel model through a generalized estimating equation 
(GEE) framework with a binomial distribution and logit link. To account for each intra-
township correlation, we specified an exchangeable correlation matrix at the township 
level. The explanatory variables in each model were specified a priori and were generally 
the same for each outcome in order to facilitate comparisons across different vaccinations. 
These variables included residency, urbanicity, township proportion non-local, and 
township CDR. To evaluate trends over time and to account for more complete records in 
SIPIS in recent years, both birth year centered at 2007 and a piecewise linear term after 
birth year 2007 were included in the models. Because PCV1 by 8 months of age only 
included children who were born in 2008 or after, the piecewise linear term was not 
included. Interactions were included for residency and 3 other variables: birth year, the 
piecewise linear term after birth year 2007, and township residency composition. Because 
of the differential probabilities of selection based on population size, we included 
population of children aged between 0 and 14 in the township as quartiles in the 
regression. We calculated estimates and standard errors for the OR of locals compared to 
non-locals in different strata by combining main and interaction coefficients Plots of odds 
ratios comparing non-locals to locals by township residency composition and at different 
birth years were constructed to facilitate interpretation of models. The precision of results 
was evaluated through 95% confidence intervals. All analyses were performed with R 
version 3.0.3 [26], including the packages geepack [27], plotrix [28], and ggplot2 [29]. 
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Ethics statement 
 This study was exempted from ethical approval by the University of Michigan 
Institutional Review Board and a Shanghai CDC ethics committee because it was limited to 
analysis of previously de-identified data. 
 
RESULTS 
 A sample of 416,750 young children was drawn from SIPIS for the study. The 
majority of children in the sample were non-locals (61.2%), male (53.1%), and lived in 
Shanghai’s suburban district (87.9%). Starting with the 2007 year, at which point SIPIS was 
widely used throughout the city, over 35,000 children born in each subsequent year were 
selected into the study (Table 3-1) with 24 townships represented in the sample. The CDR 
ranged from 7.9 to 15.5 in the sample, with a median of 10.6. The proportion of non-locals 
in the townships varied between 17% and 74%, and the median was 66% (Table 3-2). 
 Table 3-3 shows the distribution of vaccination outcomes in the total sample and by 
residency. The proportion of children with timely M1 was 83.6% and with timely MMR1 
was 87.2%. Very few children had PCV1 administered by 8 months (3.7%) or 4 years 
(7.3%). Locals had more timely measles vaccinations and greater uptake of PCV, but PPSV1 
coverage was higher among non-locals (32.2%) than locals (27.7%) at 4 years of age. 
 Findings from the multivariable regressions are shown in Table 3-4. For children 
born in 2007 who lived in local-majority townships, non-locals had lower odds of timely 
measles vaccinations and lower odds of PCV administration by 8 months or 4 years than 
locals. The odds of PPSV1 by 4 years of age were similar for locals and non-locals. 
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 Local children had worse vaccination outcomes in non-local majority townships 
than in local-majority townships, except for PCV1 by 4 years of age (OR: 1.94; 95% CI: 1.80, 
2.10). And the interaction terms between individual residency status and township 
residency composition reveal that living in non-local-majority townships leads to 
differentially worse vaccination outcomes for non-locals than for locals. For instance, non-
locals have 0.84 times the odds of timely M1 compared to locals, when living in non-local-
majority townships (95% CI: 0.80, 0.88).  
 The ORs comparing non-locals and locals across select years and different township 
settings are graphically depicted in Figure 3-2. Except for MMR1 timeliness, the disparity in 
vaccination outcomes between non-locals and locals decreased over time. Additionally, 
there is less of a difference between non-locals and locals in local-majority townships than 
in non-local-majority townships. 
 People living in townships with an above-median CDR had less timely M1 (OR: 0.93; 
95% CI: 0.91, 0.96) and MMR1 (OR: 0.87; 95% CI: 0.84, 0.90) than those from townships 
with a below-median CDR. The opposite direction of association was seen for 
pneumococcal vaccinations. The odds of PCV1 by 8 months of age (OR: 1.25, 95% CI: 1.19, 
1.32), PCV1 by 4 years of age (OR: 2.40, 95% CI: 2.29, 2.52) and PPSV1 by 4 years of age 
(OR: 1.32, 95% CI: 1.28, 1.37) were higher for those living in townships with an above-
median CDR compared to those from townships with a below-median CDR.  
 
DISCUSSION 
 Before widespread vaccination in China, 3 to 4 million cases of measles [30] and 
almost 700,000 cases of IPD [19] occurred each year. Measles and pneumococcal vaccine 
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programs have great potential to reduce morbidity, especially in young children, but we 
found that many children in Shanghai were vaccinated late; timeliness of measles 
vaccinations was below herd immunity thresholds, and the few children who did receive a 
pneumococcal vaccine usually were vaccinated after they were 8 months of age. These 
vaccination patterns mean that young infants in China are still at risk for highly infectious 
diseases, even though vaccines are available. 
Our findings that less than 90% received timely vaccination in Shanghai was similar 
to what we previously found in Tianjin, another large municipality in China [14]. One other 
study in China, in Zhejiang, a province which borders Shanghai, found relatively lower 
timely M1; there, only 70.1% of children had timely M1 [13]. Timeliness of MMR1 was 
similar in our study and in studies from developed countries: Dannetun et al. found MMR1 
timeliness between 80% and 90% in 3 different cohorts in Sweden [31], and about 90.4% 
of American parents who did not intentionally delay vaccination had timely MMR1 
according to the 2003 National Immunization Survey [32]. In each case, timely coverage of 
measles vaccinations is below critical vaccination coverage levels [33]. In spite of several 
studies suggesting that there is high coverage of measles and other EPI vaccines [13,14,34], 
this lack of vaccine timeliness in China, could be one explanation for the difficulty in 
eliminating vaccine-preventable diseases as evidenced by China inability to meet with 
2012 measles elimination target [12]. 
We found very low uptake of PCV. Corroborating our findings is a survey of parents 
across all provinces in mainland China, which found that only 9.9% of children had 
received this vaccine [35]. In contrast, in the 73 countries eligible for financial support 
from the GAVI Alliance, uptake of the third dose of PCV, a more stringent standard than 
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what we or Zheng et al. investigated, was 19% [36]. It is concerning that China, which is too 
wealthy to be eligible for GAVI funding, has lower coverage than these countries many of 
which are presumably poorer and have fewer resources to devote to immunization 
programs. Although academics and Chinese public health officials have called for China to 
introduce PCV as a government-funded vaccine [16], Che et al. indicated that this may not 
be cost-effective [37] and it does not appear to be a current government priority to 
increase PCV uptake. However, to eliminate disparities between different socioeconomic or 
demographic groups, government funding is likely to be necessary, and newer, higher-
valent vaccines than the 7-valent PCV may be more cost-effective in China. 
Urbanicity in China is correlated with many other factors, with more urban areas 
characterized as economically developed and their residents having better psychological 
and physical health compared to counterparts in less urban areas [38]. We found M1 and 
MMR1 timeliness, as well as PPSV administration, to be higher in suburban districts 
compared to urban districts. This positive association may indicate higher levels of 
immunization system performance in suburban districts or suburban residents expressing 
more positive social norms towards paid vaccines. Conversely, PCV1 administration, by 
both 8 months and 4 years, is lower in suburban districts compared to urban districts, 
indicating more sensitivity to higher prices in the economically less-developed suburban 
districts. 
Vaccination outcomes, except for PPSV uptake, were lower in non-locals than locals. 
Considering that there is substantial clustering of people by residency within China, these 
low vaccination levels indicate that there may be particular difficulty in controlling the 
spread of measles and pneumococcal disease within the non-local population.  Moreover, 
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non-locals had even worse outcomes in non-local-majority townships compared to local-
majority townships. This disparity may result from other factors associated with non-local-
majority townships, such as low socioeconomic status, or it may be because different types 
of migrants live in different settings within Shanghai [39]. For instance, more prosperous 
migrants may move to areas with fewer non-locals. 
 Regarding CDR, there was a clear delineation between patterns for M1 and MMR1 
timeliness and for pneumococcal vaccinations. A larger CDR was associated with worse 
timeliness; because a larger CDR indicates a larger concentration of children in the 
township, this could make it difficult for township immunization clinics to organize 
services so that children are vaccinated within a constrained time period. However, a larger 
CDR was associated with greater propensity for pneumococcal vaccination, suggesting that 
a greater number of children in someone’s living area may be accompanied by a 
commensurate increase in social norm that prompts parents to seek vaccination for their 
child. 
 
Strengths and limitations 
 This study has a number of limitations. We used immunization information system 
data from Shanghai to calculate vaccination coverage which limited us to data since the 
year 2000, but data before 2008 were sparse and SIPIS was not comprehensively used 
throughout the city until after 2010. Although absolute numbers may be biased and may 
overestimate vaccination outcomes, especially for earlier years, the relative comparison 
between outcomes should be reasonably unbiased, as the degree of missing data should 
follow a similar pattern for all vaccines considered. Additionally, attrition is a problem, 
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because children who move away from Shanghai may still be present in the dataset. We did 
not pursue sensitivity analyses comparing a full dataset and a smaller dataset with children 
for whom we know records exist at a given age, because the methods of limiting the dataset 
could also plausibly be related to both the explanatory variables and vaccination outcomes, 
and thus create a collider bias. Finally, the SIPIS dataset includes few individual-level 
variables. Income, education, and personal beliefs towards health care services could 
confound the relationship between residency status or township characteristics and 
vaccination outcomes. However, this study population does form a representative sample 
of children in Shanghai, and we were able to observe characteristics associated with rare 
outcomes (like PCV uptake) because of the large sample size. 
 
Conclusions  
 Although limited in their ability to obtain data on individual-level behaviors, 
immunization information systems have the goal to not only collect data, but also analyze it 
and use it to evaluate and improve public health practices [40,41]. As an information 
system becomes more comprehensive, it can become better at predicting areas with low 
vaccination coverage, hot spots for potential disease outbreaks, clinics which have 
difficulties in organizing immunization services, and populations that are, or are not, 
willing to obtain novel immunizations. As China increases efforts to eliminate measles, it 
should ensure that immunization services as a whole improve; vaccination against measles 
should not be the only end goal, but it should be a means and opportunity to improve 
programs that provide immunizations against other diseases [42]. To this end, both 
measles vaccination timeliness and pneumococcal vaccination could be used as standard 
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indicators of different but equally important aspects of immunization program 
performance. 
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Figure 3-1. Map of 24 townships in 
Shanghai selected into sample. 
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Table 3-1. Distribution of demographic characteristics overall and by residency status 
within a sample of children from the Shanghai Immunization Program Information System. 
  Locals Non-locals 
 Count (%a) Count (%b) Count (%b) 
Overall 416,750 (100%) 161,801(38.8%) 254,949 (61.2%) 
Sex    
     Male 221,283 (53.1%) 83,452 (37.7%) 137,831 (62.3%) 
     Female 195,269 (46.9%) 78,252 (40.1%) 117,017 (59.9%) 
Birth year    
     2000 5,428 (1.3%) 3,873 (71.4%) 1,555 (28.7%) 
     2001 5,669 (1.4%) 3,719 (65.6%) 1,950 (34.4%) 
     2002 6,951 (1.7%) 4,222 (60.7%) 2,729 (39.3%) 
     2003 7,224 (1.7%) 3,704 (51.3%) 3,520 (48.7%) 
     2004 11,341 (2.7%) 5,266 (46.4%) 6,075 (53.6%) 
     2005 21,185 (5.1%) 8,883 (41.9%) 12,302 (58.1%) 
     2006 30,478 (7.3%) 11,695 (38.4%) 18,783 (61.6%) 
     2007 37,995 (9.1%) 15,146 (39.9%) 22,849 (60.1%) 
     2008 40,953 (9.8%) 14,269 (34.8%) 26,684 (65.2%) 
     2009 41,415 (9.9%) 13,769 (33.3%) 27,646 (66.8%) 
     2010 44,560 (10.7%) 16,103 (36.1%) 28,457 (63.9%) 
     2011 46,117 (11.1%) 16,216 (35.2%) 29,901 (64.8%) 
     2012 53,928 (12.9%) 19,932 (37.0%) 33,996 (63.0%) 
     2013 47,132 (11.3%) 17,752 (37.7%) 29,380 (62.3%) 
     2014 16,374 (3.9%) 7,252 (44.3%) 9,122 (55.7%) 
Urbanicity    
     Urban 50,628 (12.2%) 27,292 (53.9%) 23,336 (46.1%) 
     Suburban 366,122 (87.9%) 134,509 (36.7%) 231,613 (63.3%) 
Notes: 
a Proportion of children with that characteristic. 
b Proportion of children with that characteristic who are local or non-local. 
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Table 3-2. Distribution of the child-dependency ratio (CDR) and proportion non-local in 
the townships within a sample of young children from the Shanghai Immunization Program 
Information System. 
 Range Mean (SD) Median 
CDR 7.9 – 15.5 11.3 (1.8) 10.6 
Proportion non-local 0.17 – 0.74 0.60 (0.13) 0.66 
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Table 3-3. Distribution of vaccination outcomes overall and by residency status within a 
sample of children from the Shanghai Immunization Program Information System. 
   Locals Non-locals 
 Number Proportion Proportion Proportion 
Timely M1 339,483 83.6% 89.7% 79.6% 
Timely MMR1 276,405 87.2% 92.1% 83.8% 
PCV1 by 8 months 266,100 3.7% 6.6% 2.1% 
PV by 4 years 230,195    
     PCV1  7.3% 11.3% 4.6% 
     PPSV1  30.4% 27.7% 32.2% 
Notes: 
M1, measles vaccine dose 1; MMR1, measles-mumps-rubella vaccine dose 1; PCV1, 
pneumococcal conjugate vaccine dose 1; PV, pneumococcal vaccine; PPSV1, pneumococcal 
polysaccharide vaccine 
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Table 3-4. Odds ratios and 95% confidence intervals of five different vaccination outcomes according to generalized 
estimating equations (GEE) regressions from a sample of young children from the Shanghai Immunization Program 
Information System. 
 
 
Timely M1 Timely MMR1 PCV1 by 8 mo. PCV1 vs no PV PPSV1 vs no PV 
 
n=339,483 n=276,405 n=266,100 n=160,273 n=213,486 
Main effects      
Non-local vs local 0.44 (0.42, 0.47) 0.27 (0.25, 0.30) 0.36 (0.31, 0.41) 0.73 (0.67, 0.80) 0.99 (0.94, 1.04) 
Birth year (centered at 2007) 0.99 (0.98, 1.01) 1.57 (1.55, 1.60) 1.32 (1.29, 1.34) 1.36 (1.33, 1.38) 1.23 (1.21, 1.24) 
Change after birth year 2007 1.06 (1.04, 1.08) 1.26 (1.21, 1.31) 
 
0.67 (0.64, 0.69) 0.69 (0.67, 0.71) 
Suburban vs urban district 1.07 (1.04, 1.11) 1.21 (1.14, 1.28) 0.55 (0.51, 0.59) 0.30 (0.28, 0.32) 2.37 (2.26, 2.49) 
Township residency composition (non-local 
majority vs local majority) 0.89 (0.85, 0.93) 0.31 (0.29, 0.34) 0.64 (0.59, 0.70) 1.94 (1.80, 2.10) 0.80 (0.76, 0.84) 
Township CDR (above vs below median) 0.93 (0.91, 0.96) 0.87 (0.84, 0.90) 1.25 (1.19, 1.32) 2.40 (2.29, 2.52) 1.32 (1.28, 1.37) 
Township population 
          2nd vs 1st quartile 1.17 (1.14, 1.21) 1.95 (1.85, 2.05) 0.74 (0.69, 0.80) 0.46 (0.42, 0.49) 0.75 (0.72, 0.79) 
     3rd vs 1st quartile 0.87 (0.84, 0.90) 1.48 (1.41, 1.55) 1.00 (0.92, 1.08) 0.89 (0.83, 0.95) 0.52 (0.50, 0.55) 
     4th vs 1st quartile 0.79 (0.77, 0.82) 1.80 (1.71, 1.90) 1.27 (1.17, 1.39) 0.51 (0.47, 0.55) 1.00 (0.96, 1.05) 
      
Interactions      
Non-local*birth year 1.08 (1.06, 1.09) 0.85 (0.83, 0.86) 1.08 (1.05, 1.11) 1.10 (1.07, 1.13) 1.11 (1.09, 1.13) 
Non-local*change after birth year 2007 1.00 (0.97, 1.02) 1.20 (1.15, 1.25)  0.93 (0.88, 0.98) 1.05 (1.01, 1.08) 
Non-local*non-local-majority township 0.84 (0.80, 0.88) 1.08 (1.00, 1.17) 0.63 (0.57, 0.69) 0.54 (0.49, 0.58) 0.82 (0.78, 0.86) 
Notes: 
CDR, child dependency ratio; M1, measles dose 1; mo., month; MMR1, measles-mumps-rubella dose 1; PCV1, pneumococcal 
conjugate vaccine dose 1; PV, pneumococcal vaccine; PPSV1, pneumococcal polysaccharide vaccine dose 1. 
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Figure 3-2. Odds ratios and 95% confidence intervals comparing vaccination outcomes in 
non-locals vs locals by birth year and township residency composition (black boxes 
indicate local-majority townships, white boxes non-local-majority townships). M1, measles 
vaccine dose 1; MMR1, measles-mumps-rubella vaccine dose 1; PCV, pneumococcal 
conjugate vaccine; PPSV, pneumococcal polysaccharide vaccine. 
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Supplemental Figure 3-S1. Comparison of the distributions of proportion non-locals in 
township and child dependency ratio in township in the China Census 2010 and in a sample 
of young children from the Shanghai Immunization Program Information System.  
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CHAPTER 4 
Parental perceptions of measles, pneumonia, and meningitis vaccines: a cross-
sectional survey in Shanghai, China 
 
ABSTRACT 
 
Background. In China, the measles vaccine is offered for free whereas the pneumococcal 
vaccine is a for-fee vaccine. This difference has the potential to influence how caregivers 
evaluate whether a vaccine is important or necessary. Yet other factors, such as health 
beliefs (e.g., regarding vaccine effectiveness or disease prevalence) or experience (e.g., 
disease experience or nonlocal vs local residency) are also relevant. This study compares 
parental perceptions of different diseases (measles, pneumonia and meningitis); and 
characterizes associations between Health Belief Model constructs and both pneumococcal 
vaccine uptake and perceived vaccine necessity. 
Methods. Caregivers of infants and young children between 8 months and 7 years of age 
from Shanghai (n=619) completed a written survey on their perceptions of measles, 
pneumonia, and meningitis. We used logistic regression models to assess predictors of 
pneumococcal vaccine uptake and vaccine necessity.  
Results. Only 25.2% of children had received a pneumococcal vaccine, although most 
caregivers believed that pneumonia (80.8%) and meningitis (92.4%), as well as measles 
(93.2%), vaccines were serious enough to warrant a vaccine. Perceived safety was strongly 
associated with both pneumococcal vaccine uptake and perceived vaccine necessity, and 
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non-locals had 1.70 times higher odds of pneumonia vaccine necessity than non-locals (95% 
CI: 1.01, 2.88). 
Conclusion. Most factors had a similar relationship with vaccine necessity, regardless of 
disease, indicating a common mechanism for how Chinese parents decided what vaccines 
are necessary. Because more parents believed meningitis needed a vaccine than 
pneumonia, health care workers should emphasize pneumococcal vaccination’s ability to 
protect against meningitis.  
 
INTRODUCTION 
 The provision of free vaccines through the government-funded Expanded Program 
on Immunization (EPI) has been a successful mechanism to control many infectious 
diseases [1,2]. The EPI in China started in 1978 with funding for the tuberculosis, polio, 
measles, pertussis, diphtheria, and tetanus vaccines. Since then, it has expanded to include 
hepatitides A and B, meningococcal meningitis, Japanese encephalitis, rubella, and mumps 
vaccines [1].  
Immunization clinics in China also offer non-EPI vaccines to children for a fee, 
including influenza, varicella, Haemophilus influenzae type b (Hib), rotavirus, and 
pneumococcal vaccines, among others. The pneumococcal vaccine in particular is a prime 
candidate for inclusion on the EPI schedule given the burden of pneumococcal disease [3]. 
It has been introduced in many low-income countries with support from Gavi [4], and it 
could prevent some of the 261,000 cases and 11,000 deaths due to pneumococcal 
pneumonia and meningitis in Chinese children under 5 years of age [5].  
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Non-EPI vaccines have lower childhood coverage than EPI vaccines in China [6] 
because they are not required for school entry and are expensive for parents [7]; for 
example, 7-valent pneumococcal conjugate vaccine costs approximately 135 USD per dose 
and 23-valent pneumococcal polysaccharide vaccine is approximately 24 USD per dose. 
Given the current lack of government funding for pneumococcal vaccination, 
understanding Chinese parents’ perceptions about this non-EPI vaccine and the diseases it 
prevents is key to developing effective interventions to increase vaccine uptake. And, if 
pneumococcal vaccine is added to the EPI schedule, understanding parental perceptions of 
it will be important for developing effective programs to increase people’s acceptance of 
the vaccine. 
 Vaccine decision-making can be explained by health behavior models like the Health 
Belief Model (HBM) [8], which can conceive of vaccination behaviors as an output of an 
individual’s perceptions of both a disease and its related vaccine [9]. These constructs 
specifically include people’s perceived susceptibility or vulnerability to the disease, their 
understanding of disease severity, a sense of the potential benefits of vaccination, and 
anticipated barriers to vaccination [9]. Vaccine decision-making can also be influenced by 
demographic characteristics, such as residency and urbanicity. Non-locals or migrants from 
rural areas to urban cities [10], have less access to governmental entitlement programs 
than locals [10,11], but still receive EPI vaccines for free; and urban districts represent 
historical business areas, whereas suburban districts are more industrial [12] and have less 
access to public services [13]. 
 Although previous studies in China have shown the usefulness of an HBM 
framework for understanding perceived dysentery vaccine need [14], influenza vaccination 
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intent [15], and influenza vaccine uptake among healthcare workers [16], no previous 
study in China has contrasted perceptions towards EPI and non-EPI vaccines. It may be that 
people think differently about vaccines, such as the measles and pneumococcal vaccines, 
which have divergent payment mechanisms, which vary by length of time on the market, 
and for which people plausibly have different levels of personal experience. In this study, 
we compare perceptions of pediatric measles and pneumococcal vaccinations among 
parents in Shanghai, and we characterize the associations between HBM constructs and 
both pneumococcal vaccine uptake and perceived vaccine necessity. 
 
MATERIALS AND METHODS 
Study population 
 In this cross-sectional study which took place during May and June of 2014, we 
invited caregivers of young children at immunization clinics in Shanghai to participate in a 
brief survey, which focused on their perceptions of vaccines for measles, pneumonia, and 
meningitis. We selected caregivers into the study through two-stage, stratified, cluster 
sampling, calculating the sample size to detect a 10% difference in an outcome (81% vs 
91%), with an intraclass correlation coefficient of 0.024 and a within-cluster sample size of 
20. Clusters in this sample refer to townships, which are administrative regions below 
districts in China and which are each served by an immunization clinic. Townships were 
selected by a probability proportionate to size (PPS) systematic selection procedure with 
population of children 0 to 14 years of age from the China 2010 Census as the population 
size. Figure 4-1 shows the location of the township immunization clinics in Shanghai used 
for data collection. 
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 Within each township immunization clinic, we selected a convenience sample of 20 
to 30 caregivers who accompanied their child for a vaccination visit. The sole eligibility 
criterion was that the child was between 8 months and 7 years of age, meaning they were 
old enough to receive the measles and pneumococcal vaccines. We attempted to sample an 
equal number of locals and non-locals at each clinic. The analysis included sampling 
weights so that our study population resembled the population structure of locals and non-
locals in Shanghai. 
All potential participants gave informed consent prior to participation, and 
completed the survey at the immunization clinic. The survey took approximately 20 
minutes to complete, and participants were given an incentive of 30 RMB (5 USD). The 
study protocol was approved by the Health Sciences & Behavioral Sciences Institutional 
Review Board at the University of Michigan and an ethical review committee at the 
Shanghai Centers for Disease Control and Prevention. 
 
Questionnaire 
The questionnaire collected information on caregiver perceptions of pediatric 
vaccines, in general, and measles and pneumococcal vaccines, more specifically. The 
questions were informed by previous literature on beliefs and perceptions of vaccine-
preventable diseases [17–22], as well as a qualitative, pilot research project undertaken by 
the lead author on 23 parents and grandparents at immunization clinics in Tianjin, China, 
during the summer of 2013 [23]. For a portion of the questionnaire, the same questions 
were asked about all three diseases (hereafter indicated as [disease type]): measles, 
pneumonia, or meningitis.  
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Outcome variables  
The first outcome considered was pneumococcal vaccine uptake, which was 
administration of either pneumococcal conjugate vaccine or pneumococcal polysaccharide 
vaccine. Because coverage of measles vaccine, which is part of the EPI, approaches 100% in 
China, we chose another outcome to allow us to compare how people make decisions about 
both measles and pneumococcal vaccines. This outcome, “vaccine necessity,” was the 
response to the question “Do you think that [disease type] is a serious enough disease to 
warrant a vaccine?”  
Predictor variables 
We included one question to measure each HBM construct, which were measured 
on a 5-point Likert scale. Perceived prevalence of the disease from the question “How 
common is [disease type] in your community?”. We measured perceived prevalence instead 
of the typical construct of perceived susceptibility because of feedback from the qualitative 
interviews. Previous studies have also made this substitution [24,25] and have found 
strong correlations between these two concepts [26,27].  
The vaccine-related questions were asked twice, once for the measles vaccine and 
once for the pneumococcus vaccine (hereafter indicated as [measles / pneumococcus]). 
Perceived effectiveness of vaccine from the question, “How effective do you think the 
[measles / pneumococcus] vaccine is in preventing all cases of [disease type]?”; and 
perceived safety of the vaccine from the question, “How safe is the [measles / 
pneumococcus] vaccine?”. Perceived effectiveness of vaccine and perceived safety of 
vaccine represent the HBM constructs of perceived benefits and barriers to a health-related 
action, respectively. 
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We also included questions on disease experience and descriptive norm of 
vaccination, which are not HBM constructs but which were identified as important in the 
qualitative research project [23]. Experience with the disease was a binary variable, with 
the “yes” option being a positive response to any of the following questions: “Have you ever 
personally contracted [disease type]?”; “Has your child ever contracted [disease type]?”; 
and “Has any close family member of friend of yours ever contracted [disease type]?”. 
Finally, perceived norm of vaccination was derived from the question, “Among your social 
group, how many children do you think are vaccinated against [measles / pneumococcus]?”. 
Local or non-local status was based on a previously completed field in the child’s 
vaccination booklet. Urbanicity was based on the location of the clinic: the urban districts 
include Huangpu, Xuhui, Changning, Jing'an, Putuo, Zhabei, Hongkou, Yangpu; and the 
suburban districts are Minhang, Baoshan, Jiading, Pudong, Jinshan, Songjiang, Qingpu, 
Fengxian. We did not include socioeconomic variables in the model over concerns that they 
would be mediators of the relationship between residency or urbanicity and the outcome, 
but a sensitivity analysis with education included did not significantly change any 
parameter estimates. 
 
Statistical analysis 
For a descriptive analysis, we used the non-parametric Kruskal-Wallis one-way 
analysis of variance to test for a significant difference in means for the Likert scale 
variables (df=2). A Chi-Square test of independence, with the Rao-Scott adjustment to 
account for the survey design, compared proportions for categorical variables (df=2, except 
for caregiver relation, which had df=4).  
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For pneumococcal vaccine uptake, two logistic regression models with survey 
adjustments were run—one for pneumonia-specific perceptions and the other for 
meningitis-specific perceptions. 
To compare how perceptions about measles, pneumonia, and meningitis were 
differently associated with the outcome vaccine necessity, we created a long-form dataset 
wherein each individual had 3 observations, one for their perception of each of the three 
diseases assessed. To account for each individual yielding three separate observations, we 
used a generalized estimating equation (GEE) with a binomial distribution and logit link 
and specified an unstructured correlation matrix at the individual level. An interaction 
term of each predictor variable and a dummy variable for the disease of that particular 
observation was also entered into this model. Significance of the interaction across the 3 
disease types was assessed by a Wald chi-square test (df=2, except for caregiver relation, 
which had df=4). Significance was assessed at an α level of 0.05 for all tests, and the 
precision of odds ratios (OR) was evaluated with 95% confidence intervals (CI). All 
analyses were weighted based on participants’ probability of selection with respect to 
urbanicity and residency, and we used SAS version 9.3 (SAS Institute Inc., Cary, North 
Carolina).  
 
RESULTS 
Out of 734 caregivers approached, 619 caregivers (84.3%) of children who were 
between 8 months and 7 years of age participated in the survey (Figure 4-2); nearly two-
thirds (64.5%) were mothers of the child, one-quarter (27.6%) were fathers; and 7.8% 
were other family members, mostly grandmothers. Slightly more than half of the children 
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(51.3%) were male; and 31.3% resided in Shanghai’s urban districts (Table 4-1). 
Approximately one-quarter (25.2%) of children had received a pneumococcal vaccine, and 
nearly all (98.8%) had been administered a measles vaccine. 
 All caregiver perception and experience variables were significantly different across 
the three diseases (Table 4-2). Over 90% of caregivers judged measles and meningitis 
serious enough to warrant a vaccine, whereas just over 80% thought pneumonia 
warranted a vaccine. More caregivers (43.3%) had experience with pneumonia, compared 
with 18.6% for measles and only 7.1% for meningitis. Caregivers believed that meningitis 
was more severe (mean 4.35) than measles (4.07) or pneumonia (4.11); and the perceived 
prevalence of disease was higher for pneumonia (3.15) than measles (2.30) or meningitis 
(2.28). 
 Perceived necessity of a pneumonia vaccine was the strongest predictor of 
pneumococcal vaccine uptake in the model with pneumonia-specific perceptions (OR: 2.67, 
95% CI: 1.27, 5.63) (Table 4.3). Perceived safety of vaccination was a significant predictor 
in the models for both pneumonia-specific (OR: 2.39, 95% CI: 1.57, 3.63) and meningitis-
specific perceptions (OR: 2.12, 95% CI: 1.24, 3.63). 
 Results from the multivariable model of vaccine necessity are shown in Table 4-4. 
An increase in perceived norm of vaccination was associated with 1.97 times greater odds 
of measles vaccine necessity (95% CI: 1.50, 2.59) and 1.53 times greater odds of 
pneumonia vaccine necessity (95% CI: 1.23, 1.91). Perceived safety of vaccination was 
positively associated with measles (OR: 2.35; 95% CI: 1.26, 4.38), pneumonia (OR: 1.62; 95% 
CI: 1.04, 2.52), and meningitis vaccine necessity (OR: 2.11, 95% CI: 1.31, 3.40). Perceived 
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prevalence of disease was not associated with necessity for vaccination against measles, 
pneumonia, or meningitis. 
 The strength of the associations between most explanatory variables and vaccine 
necessity did not vary significantly by disease. However, the relationship between 
perceived effectiveness of vaccination and necessity of vaccination did vary by disease 
(P=0.0088); for pneumonia this was a positive association (OR: 4.05; 95% CI: 2.61, 6.31), 
whereas for measles and meningitis there was no association. There was also a significant 
interaction between urbanicity and disease (P=0.0016); people living in suburban districts 
were more likely to consider the pneumonia vaccine necessary (OR: 1.74; 95% CI: 1.01, 
3.00), whereas the opposite relationship (OR: 0.37; 95% CI: 0.15, 0.92) was found for the 
measles vaccine. Additionally, although the interaction term for residency was not 
significant, non-locals had higher odds of pneumonia vaccine necessity than locals (OR: 
1.70; 95% CI: 1.01, 2.88), whereas there was not a significant association between 
residency and either measles or meningitis vaccine necessity.  
 
DISCUSSION 
 In this cross-sectional survey of parents in Shanghai, only a minority of children had 
been administered a pneumococcal vaccine, even though most of their caregivers believed 
that pediatric pneumonia and meningitis vaccines were necessary. Moreover, whereas over 
90% of caregivers thought measles and meningitis were serious enough to warrant a 
vaccine, just over 80% held similar beliefs for pneumonia. Previous studies have also 
shown that parents generally do not consider pneumonia vaccines as important as other 
vaccines. In the Netherlands, Hak et al. found that fewer parents had a positive attitude 
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towards pneumonia vaccines than other vaccines, such as those for hepatitis B or 
tuberculosis [28]. Bedford and Lansley similarly reported that fewer British parents would 
accept a pneumococcal vaccine than a meningococcal vaccine. They postulated that this 
difference in acceptance came from parents associating meningococcus with meningitis 
and pneumococcus with pneumonia, and subsequently believing that meningitis was more 
clinically severe than pneumonia [29], which is corroborated by our study in comparing 
perceptions of pneumococcal meningitis and pneumococcal pneumonia. 
In this study, perceived vaccine necessity but not perceived prevalence of 
pneumonia was positively associated with pneumococcal vaccine uptake. Both our study 
and a study on pediatric dysentery vaccination by Chen et al. did not observe a relationship 
between perceived prevalence and vaccine need [14], suggesting that, for Chinese parents, 
perceptions about a disease’s threat primarily derive from their thoughts about severity 
and is not necessarily based on their understanding of how common the disease is within 
the community. It is possible that Chinese parents may view the threat of diseases in a 
fundamentally different way compared to parents in other countries because the one-child 
policy results in a lot of attention and focus from parents on one child [30]. Chinese parents’ 
consideration with their child’s safety may explain why pneumonia vaccine necessity, a 
measure of disease severity, was a strong predictor of pneumococcal vaccine uptake and 
why perceived vaccine safety was strongly and positively associated with all vaccine 
outcomes that we considered.  
 Besides perceived safety of vaccination, necessity of pneumonia vaccination was 
also associated with pneumococcal vaccine uptake. Vaccine necessity could be an 
important mediator in the pathway between disease perceptions and vaccine uptake, and 
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we may observe stronger associations between disease perceptions and vaccine necessity 
than disease perceptions and vaccine uptake because vaccine necessity is more proximal to 
these perceptions. The lack of significant associations between perceptions of meningitis 
and pneumococcal vaccination could result from caregivers not being aware that 
pneumococcal vaccines can protect against some forms of meningitis. 
 Most of the HBM constructs and other beliefs under consideration had a similar 
relationship with vaccine necessity, regardless of disease. This indicates that there was a 
common mechanism underlying how Chinese parents decided what vaccines are necessary, 
given their perceptions about the disease and the vaccine. However, the strength of the 
relationship between perceived effectiveness of vaccination and vaccine necessity did 
differ by disease. For measles, perceived effectiveness of vaccination was not an important 
determinant of vaccine necessity, perhaps because measles vaccine is mandatory. In 
contrast, because the pneumococcal vaccine requires payment from caregivers, parents 
may only perceive their children to need it if the vaccine is effective. We may not see any 
association for meningitis because the pneumococcal vaccine in China is marketed as a 
pneumonia vaccine, not a meningitis vaccine, and we conjecture that caregivers have little 
understanding of how the pneumococcal vaccine can prevent some forms of meningitis. 
 That measles vaccine is an EPI vaccine but pneumococcal vaccine is not prevented 
us from considering other factors that could influence vaccine uptake in other countries. 
First, measles vaccine is free in Shanghai but pneumococcal vaccine requires payment. This 
likely had a significant impact on decisions; in a 7-country survey of parents, support for a 
vaccine decreased by 14% if the vaccine required the parent to pay out-of-pocket [31]. 
Second, China has focused tremendous effort on measles elimination, and hundreds of 
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millions of children have been vaccinated against measles during supplementary 
immunization activities within the past decade [32]. These efforts could lead to the Chinese 
public receiving more information about measles than about pneumonia or meningitis.  
 Non-locals and suburban dwellers have a number of different experiences and 
attributes which distinguish them from their local or urban counterparts. They may have 
different experiences with disease, given disparities in treatment or ability to interface 
with health care providers. Notably, quality and density of health care diminishes outside 
of urban areas in cities [13], and non-locals access health care services much less than 
locals [33]. Previous studies have shown that non-locals have lower vaccination coverage 
than locals, and suburban children have worse vaccination outcomes than those in urban 
districts, for both EPI and non-EPI vaccines [6,34,35]. Yet we found that non-locals and 
suburban dwellers had greater odds of considering pneumonia vaccines as necessary 
compared to locals and urban dwellers. That these subpopulations think that pneumonia 
vaccines are necessary but do not receive could result from the cost of these expensive 
vaccines, and financial incentives from the government may be necessary to increase 
vaccination coverage, particularly in these poorer populations where there is a demand for 
vaccination. 
This study provides a framework for developing a better understanding of the 
context driving demand for a vaccine. As Nichter notes, there is a difference between 
passive acceptance of and active demand for vaccinations [36]. With passive acceptance, 
the populace attains high vaccination coverage only after the public health sector devotes 
intensive resources towards promoting a certain vaccine. By contrast, in the latter, a well-
informed public perceives the need for vaccination and drives demand for immunization 
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services. In our survey, perceived necessity of vaccination by caregivers was higher for 
measles and meningitis than it was for pneumonia. This implies that even if pneumonia 
vaccination were added to the EPI schedule, active demand could be lower than for other 
vaccines. As a result, uptake would be driven by pressure from the public health sector and 
not from caregivers demanding the vaccine. 
 
Strengths and Limitations 
 The study has both important strengths and limitations. One strength was the 
purposeful sampling of people by urbanicity and by residency to account for the important 
demographic groups in Shanghai. However, within each township, we selected a 
convenience sample from each immunization clinic. This means that the study population 
is biased towards a population with more positive views towards immunization services. 
Additionally, we only used one item to measure each HBM construct, and therefore could 
not minimize measurement error by formulating latent constructs. 
 This study evaluated perceptions of meningitis and pneumococcal vaccinations, but 
a Hib vaccine and meningococcal vaccine are also available in China to protect against these 
diseases. The etiology of pneumonia and meningitis in China is poorly understood [5,37,38], 
but it is likely that Hib results in comparable rates of pneumonia morbidity and mortality 
as pneumococcus [5,39] and that the cause of meningitis morbidity in China is somewhat 
equally divided between meningococcus and pneumococcus [5,40]. A caregiver’s 
perception of vaccine necessity could therefore be colored by the other vaccines already on 
the market, and we hypothesize that caregivers would be less apt to consider a vaccine 
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necessary if they also thought that that disease could be caused by a number of different 
infections.  
 
Conclusions 
 Given the enormous toll of pneumococcal disease in China [3,5], widespread 
pneumococcal vaccination could improve child health and save lives. China has spent 
tremendous resources on measles elimination [32], but measles elimination efforts should 
could be combined with other immunization initiatives [41], such as educating parents 
about the benefits of pneumococcal vaccination. In particular, because more people 
thought that a meningitis vaccine was necessary than a pneumonia vaccine, promotional 
materials for pneumococcal vaccines could focus disease severity and on meningitis, the 
more severe clinical presentation of pneumococcal disease.  
 Future studies could take a longitudinal look at attitudes towards a disease, the 
desire to obtain a vaccine, and, finally, actual vaccination. Additionally, both the 
relationship between the patient and the provider and how the provider approaches 
talking about vaccination are important [42], warranting further research on health care 
workers in China. As more vaccines are introduced into the EPI schedule in China, 
providers will be an important conduit of information about the risk of disease and the 
safety and effectiveness of vaccination. 
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Figure 4-1. Map of 31 township clinics 
used in the study on perceptions of 
pediatric vaccinations in Shanghai, 
summer 2014. Chongming county 
encompasses islands to the north of the 
mainland and was not included as part of 
the sample.  
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Figure 4-2. Flowchart of caregivers 
enrolled into study on perceptions of 
pediatric vaccinations in Shanghai, 
summer 2014. 
 
  
734 caregivers 
approached 
646 did 
questionnaire 
619 had old 
enough children 
602 with 
complete data for 
multivariable 
analysis 
88 refused 
27 had 
children 
outside age 
range 
17 had 
missing data 
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Table 4-1. Demographic characteristics of 619 children and their caregivers from Shanghai, 
2014. 
Characteristic Category Counta Proportionb 
(%) 
Lower 
95% CLb 
(%) 
Upper 
95% CLb 
(%) 
Caregiver relation Mother 405 64.5 59.8 69.3 
 Father 156 27.6 23.1 32.2 
 Other 57 7.8 5.5 10.1 
Parent’s agec <28 years 105 23.1 18.3 27.9 
 28 to <31 years 142 28.0 23.3 32.8 
 31 to <34 years 129 24.5 19.9 29.1 
 ≥35 years 144 24.3 19.9 28.8 
Caregiver’s education ≤Middle school 142 24.2 19.9 28.6 
 ≤High school 93 17.8 13.8 21.8 
 Some college 153 23.3 19.4 27.3 
 College graduate 227 34.6 30.1 39.2 
Family monthly income <4,000 RMB 109 19.1 15.1 23.1 
 4,000 to <6,000 RMB 142 23.9 19.6 28.2 
 6,000 to <10,000 RMB 156 26.8 22.4 31.2 
 ≥10,000 RMB 208 30.2 25.9 34.5 
Child’s sex Male 324 51.3 46.4 56.2 
 Female 292 48.7 43.8 53.6 
Child’s residency Local 315 43.2 38.5 47.8 
 Non-local 303 56.8 52.2 61.5 
Township urbanicity Urban 203 31.3 26.9 35.7 
 Suburban 415 68.7 64.3 73.1 
Pneumococcal 
vaccination 
Yes 170 25.2 21.0 29.3 
 No 448 74.8 70.7 79.0 
Measles vaccination Yes 609 98.8 98.0 99.7 
 No 9 1.2 0.3 2.0 
Notes: 
CL, confidence limit. 
a Unweighted. 
b Weighted. Proportion does not include missing values. 
c Only for mothers and fathers. 
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Table 4-2. Perceptions of measles, pneumonia, and meningitis disease and vaccination among caregivers in Shanghai, 2014. 
 Measles  Pneumonia  Meningitis  
 N Estimate SE  N Estimate SE  N Estimate SE P-value* 
Vaccine necessity (%) 609 93.2 1.15  610 80.8 1.89  613 92.4 1.34 <0.0001 
Perceived severity 618 4.07 0.040  618 4.11 0.039  616 4.35 0.035 <0.0001 
Perceived prevalence 616 2.30 0.043  618 3.15 0.047  617 2.28 0.037 <0.0001 
Disease experience (%) 618 18.6 1.96  618 43.3 2.44  618 7.1 1.40 <0.0001 
Perceived norm 614 4.03 0.045  612 3.35 0.051  612 3.35 0.051 <0.0001 
Perceived effectiveness 615 3.81 0.033  615 3.58 0.032  616 3.56 0.035 <0.0001 
Perceived safety 617 3.92 0.036  617 3.81 0.034  617 3.81 0.034 0.0404 
Notes: 
SE, standard error. 
* For Likert scale variables, the P-value is the Kruskal-Wallis test. For dichotomous variables, the P-value is from the Rao-Scott 
Chi-Square Test. 
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Table 4-3. The relationship between both pneumonia-specific and meningitis-specific perceptions 
and pneumococcal vaccine uptake according to multivariate logistic regression models from a 
study of 602 caregivers in Shanghai, 2014. 
  Pneumonia 
OR (95% CI) 
Meningitis 
OR (95% CI) 
Perceived vaccine necessity 2.67 (1.27, 5.63) 1.45 (0.52, 3.99) 
Perceived prevalence 1.10 (0.84, 1.44) 0.97 (0.73, 1.31) 
Disease experience   
     Yes vs No 1.16 (0.70, 1.94) 1.32 (0.55, 3.17) 
Perceived norm 1.16 (0.92, 1.46) 1.21 (0.96, 1.53) 
Perceived effectiveness 0.91 (0.61, 1.35) 0.95 (0.61, 1.47) 
Perceived safety 2.39 (1.57, 3.63) 2.12 (1.24, 3.63) 
Residency   
     Non-local vs local 1.01 (0.63, 1.60) 0.97 (0.62, 1.52) 
Urbanicity   
     Outer vs inner district 1.10 (0.69, 1.78) 1.31 (0.82, 2.08) 
Caregiver relation   
     Father vs mother 0.71 (0.41, 1.24) 0.67 (0.39, 1.17) 
     Other vs mother 1.54 (0.71, 3.32) 1.20 (0.56, 2.53) 
Notes: 
OR: odds ratio; CI: confidence interval 
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Table 4-4. Results from a single, multivariable logistic regression model of necessity of 
vaccination for three diseases from a study of 602 caregivers in Shanghai, 2014. 
  Measles 
OR (95% CI) 
Pneumonia 
OR (95% CI) 
Meningitis 
OR (95% CI) 
P-valuea 
Perceived prevalence 1.25 (0.85, 1.83) 1.18 (0.91, 1.53) 1.08 (0.65, 1.80) 0.9022 
Disease experience    0.2576 
     Yes vs No 1.48 (0.58, 3.78) 0.76 (0.46, 1.26) 0.34 (0.10, 1.10)  
Perceived norm 1.97 (1.50, 2.59) 1.53 (1.23, 1.91) 1.13 (0.80, 1.61) 0.0753 
Perceived effectiveness 1.31 (0.69, 2.49) 4.05 (2.61, 6.31) 1.17 (0.57, 2.42) 0.0088 
Perceived safety 2.35 (1.26, 4.38) 1.62 (1.04, 2.52) 2.11 (1.31, 3.40) 0.5349 
Residency    0.4511 
     Non-local vs local 1.77 (0.84, 3.73) 1.70 (1.01, 2.88) 1.06 (0.48, 2.36)  
Urbanicity    0.0016 
     Suburban vs urban 0.37 (0.15, 0.92) 1.74 (1.01, 3.00) 0.79 (0.32, 1.95)  
Caregiver relation    0.1886 
     Father vs mother 0.38 (0.17, 0.84) 1.21 (0.64, 2.27) 1.07 (0.44, 2.56)  
     Other vs mother 0.20 (0.06, 0.65) 0.50 (0.21, 1.17) 0.45 (0.14, 1.48)  
Notes: 
OR: odds ratio; CI: confidence interval 
a Wald chi-square test for overall interaction (df=2, except for caregiver relation, which had 
df=4) 
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CHAPTER 5 
Conclusions 
 
In this concluding chapter, I will review the important findings of my dissertation’s 
three studies within the context of existing literature. Then, I will focus on a discussion of 
the role of non-locals in vaccine-preventable disease transmission. After a discussion of the 
limitations and strengths of the analyses, this chapter concludes with a discussion of future 
research directions. 
Overall, this dissertation focuses on two vaccine-preventable infections in order to 
better generalize the experience of vaccinations in China beyond one particular example. 
Measles vaccine is a free and has been on the EPI in China since 1978 [1]. There has been 
tremendous attention placed on measles in China and worldwide for its elimination effort 
[2]. Conversely, the pneumococcal vaccine has only been more recently introduced to the 
Chinese market and it is prohibitively expensive for many Chinese. Although it has been 
listed on the EPI schedule of many countries, including those less developed than China [3], 
China has resisted calls to publically fund this vaccine [4]. Overall, we answer the questions 
“What are the differences between locals and non-locals in disease incidence and 
vaccination outcomes in China?” and “What are the similarities and differences between 
measles and pneumococcal vaccination programs in China?”  
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Study 1 Review 
 In this study, we used data from the Tianjin notifiable disease registry to 
characterize temporal trends in measles incidence by residency (non-local versus local) 
and to evaluate the impact of SIAs on measles incidence. Before 2008, the rate of measles in 
non-locals was much higher than in locals in Tianjin, but after two SIAs within two years, 
there were fewer cases of measles and the disparity between locals and non-locals was 
eliminated. Previous studies have found SIAs to be important for reducing incidence in the 
Americas[5], in Eastern Europe[6], and in China [7]. Many previous studies have measured 
the impact of an SIA by comparing rates in the years before the SIA compared to the year 
after [7], but we caution against this practice. After an SIA, a new cohort of children is born, 
and this population of susceptible individuals can potentiate future outbreaks. In our study 
we observed an increase in measles cases among young infants and young adults in 2010, 
two years after the first municipality-wide SIA. A similar pattern was found three years 
after an SIA in Xinjiang, China [7]. Evaluation of measles incidence for several years after an 
SIA is therefore important to not ascribe too much success to an SIA, which instead of 
comprehensively reducing measles incidence may have shifted the burden of disease to 
later birth cohorts or established a biennial cycle of measles transmission. 
 An additional reason that could explain increases in measles incidence after an SIA 
is the accumulation of susceptibles through migration [8,9]. Migrants may be unvaccinated, 
particularly if their place of origin did not have an SIA. China’s switch from implementing 
disparately-timed SIAs before 2009 to a synchronized national event in 2010 may be one 
explanation for why we still saw a disparity in measles incidence by residency in the two 
years after the first SIA, but not after the second SIA.  
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Study 2 Review 
This study explored vaccination outcomes in terms of timely M1 and MMR1 
administration as well as uptake of PCV and PPSV by certain milestone ages. Specifically, 
we estimate the proportion of children in Shanghai with these vaccination outcomes, 
compare vaccination outcomes in non-locals and locals, and assess the impact of township-
level characteristics on vaccination outcomes. 
Timeliness of measles vaccinations was 90%, below herd immunity thresholds. This 
is similar to  what we previously described in Tianjin [10], and what has been found by 
others in Zhejiang, China [11], in the US [12], and in Sweden [13]. In each case, timeliness of 
measles vaccine administration was below levels sufficient to interrupt transmission of 
disease [14]. The lack of timeliness in measles vaccinations, in spite of several studies 
suggesting that there is high coverage of measles and other EPI vaccines [10,11,15], could 
be one explanation for the difficulty in eliminating vaccine-preventable diseases in China 
[16]; for example, China missed the 2012 measles elimination target [16]. 
China has resisted funding pneumococcal vaccination despite calls to do so [4], and 
in spite of a general recommendation from the WHO for all countries to publically fund the 
vaccine [17]. We accordingly found pneumococcal vaccination to be extremely low. 
Another study in China also found low uptake of pneumococcal vaccination [18], which 
sharply  contrasts with the 73 countries eligible for financial support from the GAVI 
Alliance. In these countries, 19% of children had the third dose of PCV, a more stringent 
standard than what we investigated [3]. It is concerning that China, which is too wealthy to 
be eligible for GAVI funding, has lower coverage than these countries. This indicates that 
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the drive for higher coverage of vaccines in China is tied to public funding, not individual 
initiative to get vaccinated. 
 Townships, administrative divisions which in Shanghai have on average over 
100,000 residents, also play a role in vaccination. Not only do these places represent the 
social milieu of parents who get their child a vaccine, but parents within a township share 
an immunization clinic. We found distinct trends in vaccination when considering our 
township-level factors of urbanicity, township residency composition, and CDR. Our 
explanation for these patterns follows. Urbanicity in China is correlated with many other 
factors, with more urban areas being more economically developed and their residents 
having better psychological and physical health compared to counterparts in less urban 
areas [19]. That PCV1 coverage is lower in outer districts compared to inner districts 
indicates more sensitivity to higher prices in the economically less-developed outer 
districts. Residency composition may point to social norms. In our third aim, we found that 
non-locals have higher perceived need of pneumonia vaccination, and so locals living near 
more non-locals may accordingly have higher uptake as a result of this norm. Our last 
township-level factor, CDR, measures the relative number of children in a township. A 
higher CDR was associated with worse timeliness of measles, perhaps because more 
children make it difficult for township immunization clinics to organize services so that 
children are vaccinated within a constrained time period. Future research could directly 
compare these township-level factors to directly-measured vaccination norms. 
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Study 3 Review 
Our third study compared perceptions of pediatric measles and pneumococcal 
vaccinations among parents in Shanghai, and characterized the associations between HBM 
constructs, demographic characteristics, and perceived vaccine necessity, by disease. We 
found that people were more likely to think measles and meningitis vaccines were 
necessary than pneumonia vaccines. Previous studies in the Netherlands [20] and in the 
United Kingdom [21] have echoed this sentiment that parents do not consider pneumonia 
vaccines as important as other vaccines. Moreover, we found that perceptions of disease 
severity, but not disease prevalence, influenced perceptions of vaccine need. A study on 
pediatric dysentery vaccination in China also found this pattern [22]. Because disease 
severity was more important than disease prevalence when parents thought about which 
vaccines were necessary for vaccination, and because our study participants thought that 
meningitis was more severe than pneumonia, we encourage immunization clinics to 
emphasize meningitis prevention when promoting pneumococcal vaccination. 
 
Vaccination and disease among non-locals 
 Many previous studies have indicated that non-locals, also known as migrants or the 
floating population, contribute to high measles incidence in China [7,23,24]. Non-locals 
have a number of different experiences and attributes which distinguish them from their 
local counterparts.  They may have different experiences with disease, given disparities in 
treatment and ability to interface with health care providers. Notably, quality and density 
of health care diminishes outside of urban areas in cities where non-locals tend to cluster 
[25], and non-locals access health care services much less than locals [26]. Lower 
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vaccination coverage among non-locals could be contributing to complications in 
eliminating measles, but most provinces in China have had 2 SIAs in the past decade in 
addition to offering free vaccines to all residents in routine services. Therefore, there are 
not obvious relationships among residency status, measles vaccination, and measles 
infection. A substantial focus across the three aims of this dissertation was to quantify 
discrepancies between locals and non-locals and to see if there are measurable differences 
in infection, vaccination, or vaccine attitudes by residency. 
 We did see differences by residency for all three outcomes considered, but we also 
observed trends over time. For instance, we saw higher rates of measles in non-locals than 
locals before the 2008 SIA in Tianjin, but this disparity attenuated in the two years that 
followed and was completely eliminated in the years after that. This finding contrasts with 
a study from Fujian, China [27], where the contribution of non-locals to measles incidence 
actually increased in the years after an SIA compared to before. However, the Fujian study 
observed cases from a larger catchment area than our study of Tianjin. Additionally, rapid, 
and potentially differential, urbanization in Fujian and in our study makes comparisons 
across time difficult without adequate census information.   
 We observed that non-locals had worse measles vaccination timeliness and PCV 
uptake than locals. Considering that non-locals tend to live in neighborhoods with other 
non-locals [28], low timeliness of measles vaccinations, particularly among young, non-
local infants means there may be a large pool of susceptibles in certain neighborhoods, and 
the preponderance of this population is not reflected in overall estimates of measles 
vaccine coverage. Low coverage of PCV in these young, non-local infants is also troubling 
because the clinical presentations of pneumococcal pneumonia and pneumococcal 
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meningitis is especially severe at these ages [29]. However, we did find that PPSV uptake 
was greater in non-locals than locals. This enthusiasm for vaccination was corroborated in 
our cross-sectional survey of Shanghai parents, where we found that perceived necessity of 
pneumococcal vaccination was higher in non-locals than locals. Because PPSV is a less 
expensive pneumococcal vaccine than PCV, lower uptake of PCV in non-locals relative to 
locals is probably due to worse financial circumstances in non-locals and not less 
willingness to actually get vaccinated. 
 A number of strategies could increase the overall health of the population while 
working to remove differences between locals and non-locals. For measles vaccine, which 
is free and mandatory, catch-up and follow-up SIAs offer an opportunity for everyone 
within a restricted age set to get a vaccine, regardless of their vaccination status. Because 
people are constantly moving across China, SIAs simultaneously occurring in multiple 
provinces can vaccinate people who later move across borders. Other SIA approaches are 
also available. Mop-up SIAs, which target high-risk groups, could be implemented to 
specifically target new migrants to an area, and would accordingly cost less. Ensuring that 
new migrants are enrolled at immunization clinics and other locations, like schools or 
community population registers, could facilitate enumerating this population. Being able to 
contact non-locals for SIAs is crucial, as past research has found that migrant participation 
in SIAs is lower than overall numbers [30]. Another SIA option would be a speed-up SIA, in 
which young adults are vaccinated. This approach was previously used in Europe [6] and in 
the Americas [5]. Because we also see a high burden of disease in Chinese young adults, a 
speed-up SIA could reduce incidence of disease in this population as well as cocoon their 
young children from infection. 
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 In contrast to measles vaccination, pneumococcal vaccination requires payment, 
which may particularly be a barrier for non-locals. It has been previously found that 
migrants are less willing to pay for PCV than locals in China [31], though we found that 
non-locals perceived that pneumonia vaccines were more necessary than locals. It follows 
that uptake of pneumococcal vaccines, particular PCV, is lower in non-locals and locals not 
because of decreased demand, but because they do not have the financial stability to do so. 
That non-locals do have higher coverage of PPSV, an arguably inferior vaccination which is 
unable to be administered to the youngest and most vulnerable children [32], is another 
sign that non-locals are willing to receive a vaccination, though not necessarily willing to 
pay a high cost for it. Overall, because of the substantial burden of pneumococcal 
vaccination for non-locals, to ensure equitable coverage of vaccine for both locals and non-
locals would require government funding. 
  
Strengths and Limitations 
 Like all research, this study has both strengths and limitations. In terms of 
limitations, , this dissertation was limited by residency classification. This classification 
came from official documents, like a vaccination booklet or registry database, but as more 
Chinese people migrate into cities, discerning finer distinctions between different migrant 
groups could better identify high-risk groups. Moreover, the composition of migrants likely 
has changed over time, and it is therefore difficult to compare secular trends using this 
crude demographic distinction. It is my hope that this dissertation can encourage future 
researchers to be cognizant of the limitations in defining people as being a “non-local,” 
“migrant,” or member of the “floating population.” 
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 The first two aims of this dissertation used registry data, which means that the 
analysis was limited to the available information from the registry and not necessary all 
relevant risk factors. The use of the registry also means that we did not have direct 
measures of the overall population size: only measles cases, and not healthy controls, are 
listed in NIDMIS, and SIPIS may be subject to attrition as people move out of the city. We 
were able, however, to link these datasets to population information from the China Census 
and China Statistical Yearbook. The use of population information from an outside source, 
rather than limiting ourselves to data collected within a single study, permitted us to better 
approximate population parameters and reduce selection bias that would result from 
people selecting to participate in the study. 
 Expanding the registries to encompass other information could be beneficial, 
although it is more important for there to be a limited amount of high-quality information 
than larger variety of information which may have an unacceptably high proportion of 
missing data. Nevertheless, establishing linkages between NIDMIS and other databases, like 
immunization registries, population statistical databases, and hospital records, could 
increase the usefulness of NIDMIS to identify susceptible populations and to research 
correlates of disease. Importantly, giving hospitals access to  some information within a 
limited geographic area could increase hospitals’ knowledge about their catchment area 
and increase their likelihood of providing timely, comprehensive reports of disease [33]. 
 The first two aims used datasets with longitudinal information: registries collect 
data over time. My last aim was cross-sectional. There are limitations to both approaches. 
First, registries collect information on a large amount of people, resulting in statistically 
significant results for many associations that I studied. However, statistical significance of a 
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relationship does not mean that that association is causal, or even important. In the future, 
looking at findings from a variety of studies will better allow us to identify what are the 
important factors affecting vaccination and disease incidence in the Chinese population. 
Second, for the longitudinal analyses, various trends could influence the associations we 
see beyond what we are able to directly measure. For example, decreases in measles 
incidence over time could be related to the SIAs, gradual improvements in routine 
immunization services, or changes in how measles cases were reported into the registry. 
Similarly, SIPIS has improved its completeness in collecting data over time. Third, for the 
cross-sectional study of parental perceptions, perception and vaccination outcome were 
measured at the same time, and we are not able to temporally separate the two. This 
potentially means that there is reverse causation bias in this study. 
 In the second and third aim, we compared measles and pneumococcal vaccinations 
in order to better understand immunization services in China. That measles vaccine is an 
EPI vaccine but pneumococcal vaccine is not has also made us unable to consider other 
factors that likely influence vaccine uptake in other countries. First, measles vaccine is free 
in Shanghai but pneumococcal vaccine requires payment. In a 7-country survey of parents, 
support for a vaccine decreased by 14% if the vaccine required the parent to pay out-of-
pocket [34]. Second, China has focused tremendous effort on measles elimination, and 
hundreds of millions of children have been vaccinated against measles during 
supplementary immunization activities within the past decade [35]. These efforts likely 
lead to the Chinese public receiving more information about measles than about 
pneumonia or meningitis, which can both be prevented through the pneumococcal vaccine.  
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Future work 
Future work could build upon research from my dissertation. In the first part of my 
dissertation, I used a time-series analysis to quantify the incidence rate of measles over 
time, but a spatial statistics approach could also inform us of the geographical distribution 
of this highly infectious disease. 
One consideration in my dissertation was how to classify children by residency. The 
approach I have used was to identify locals and non-locals based on the designation from 
their residency papers, which is present in official documentation like vaccination booklets 
and other immunization clinic records. However, additional factors—like socioeconomic 
status, which province non-locals came from, how long they have resided in the current city, 
and how often they return to their home province—could likely influence health seeking 
behavior. Future research could conceive of a classification scheme for residency which 
predicts vaccination attitudes and vaccination outcomes better than the binary distinction 
between locals and non-locals. For example, certain non-locals, like those who have lived in 
urban areas for much of their lives, may be more similar to locals than other non-locals. 
Identifying a more precise high-risk group for low vaccination coverage could lead to more 
targeted interventions. 
 Using this residency classification, I could develop a refined model to evaluate 
whether disparities in attitudes between different residency groups contribute to variation 
in pneumococcal vaccination uptake. For my dissertation, I used standard regression 
models, but with a mediation analysis using a structural equation model, residency could 
be the main predictor, HBM constructs could be the mediating attitudes and perceptions, 
and pneumococcal vaccination could be the outcome. 
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 Another future analysis could better characterize associations between community-
level factors and attitudes towards vaccination. Because health behaviors could be 
influenced by a number of social norms, understanding what community-level factors 
contribute to vaccination attitudes could pinpoint areas for targeted behavioral 
interventions and identify regions in the city which may potentiate future outbreaks of 
vaccine-preventable diseases.  
108 
 
REFERENCES 
 
1.  Zheng J, Zhou Y, Wang H, Liang X (2010) The role of the China Experts Advisory 
Committee on Immunization Program. Vaccine 28S: A84–A87. 
doi:10.1016/j.vaccine.2010.02.039. 
2.  McFarland J (2012) World Immunization Week, China. 
3.  GAVI Alliance (2015) Vaccine goal indicators. GAVI. Available: 
http://www.gavi.org/results/goal-level-indicators/vaccine-goal-indicators/. 
4.  Yu H, Yang W, Varma JK (2012) To save children’s lives, China should adopt an 
initiative to speed introduction of pneumonia vaccines. Heal Aff 31: 2545–2553. 
doi:10.1377/hlthaff.2011.1272. 
5.  Castillo-Solorzano C C, Matus CR, Flannery B, Marsigli C, Tambini G, et al. (2011) The 
Americas: paving the road toward global measles eradication. J Infect Dis 204 Suppl: 
S270–S278. doi:10.1093/infdis/jir166. 
6.  Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, et al. (2011) Supplementary 
immunization activities to achieve measles elimination: Experience of the European 
region. J Infect Dis 204. doi:10.1093/infdis/jir074. 
7.  Ma C, An Z, Hao L, Cairns KL, Zhang Y, et al. (2011) Progress toward measles 
elimination in the People’s Republic of China, 2000-2009. J Infect Dis 204: S447–
S454. doi:10.1093/infdis/jir103. 
8.  Marguta R, Parisi A, Parisi A (2015) Impact of human mobility on the periodicities 
and mechanisms underlying measles dynamics. J R Soc Interface 12: 20141317. 
9.  Uziel A, Stone L (2012) Determinants of periodicity in seasonally driven epidemics. J 
Theor Biol 305: 88–95. doi:10.1016/j.jtbi.2012.02.031. 
10.  Wagner AL, Zhang Y, Montgomery JP, Ding Y, Carlson BF, et al. (2014) Timely 
measles vaccination in Tianjin, China: a cross-sectional study of immunization 
records and mothers. BMC Public Health 14: 888. doi:10.1186/1471-2458-14-888. 
11.  Li Q, Hu Y, Zhong Y, Chen Y, Tang X, et al. (2014) Using the Immunization Information 
System to determine vaccination coverage rates among children aged 1-7 years: a 
report from Zhejiang Province, China. Int J Environ Res Public Health 11: 2713–2728. 
doi:10.3390/ijerph110302713. 
12.  Smith PJ, Humiston SG, Vannice KS (2010) The Association Between Intentional 
Delay of Vaccine Administration and Timely Childhood Vaccination Coverage. Public 
Heal Rep 125: 534–541. 
 109 
 
13.  Dannetun E, Tegnell A, Hermansson G (2004) Timeliness of MMR vaccination—
influence on vaccination coverage. Vaccine 22: 4228–4232. 
doi:10.1016/j.vaccine.2004.04.018. 
14.  Gay NJ (2004) The theory of measles elimination: implications for the design of 
elimination strategies. J Infect Dis 189 Suppl: S27–S35. doi:10.1086/381592. 
15.  Montgomery JP, Zhang Y, Carlson B, Ewing S, Wang X, et al. (n.d.) Measles Vaccine 
Coverage and Series Completion among Children 0 to 8 Years of Age in Tianjin, China. 
Pediatr Infect Dis J. doi:10.1097/INF.0000000000000562. 
16.  Ma C, Hao L, Zhang Y, Su Q, Rodewald L, et al. (2014) Monitoring progress towards 
the elimination of measles in China: an analysis of measles surveillance data. Bull 
World Health Organ 92: 340–347. doi:10.2471/BLT.13.130195. 
17.  WHO (2012) Pneumococcal vaccines: WHO position paper - 2012. Wkly Epidemiol 
Rec 87: 129–144. 
18.  Zheng J, Cao L, Guo S, A K, Wang L, et al. (2012) Survey of the current situation of 
category 2 vaccines in Chinese children aged 1 to 2 years. Chin J Vaccine Immun 18: 
233–237 [in Chinese]. 
19.  Liu H, Li Z (2011) Social Change and Psychological Well-being in Urban and Rural 
China. Asia Heal Policy Progr 23. 
20.  Hak E, Schönbeck Y, De Melker H, Van Essen GA, Sanders EAM (2005) Negative 
attitude of highly educated parents and health care workers towards future 
vaccinations in the Dutch childhood vaccination program. Vaccine 23: 3103–3107. 
doi:10.1016/j.vaccine.2005.01.074. 
21.  Bedford H, Lansley M (2007) More vaccines for children? Parents’ views. Vaccine 25: 
7818–7823. doi:10.1016/j.vaccine.2007.08.057. 
22.  Chen X, Stanton B, Wang X, Nyamette A, Pach A, et al. (2006) Differences in 
perception of dysentery and enteric fever and willingness to receive vaccines among 
rural residents in China. Vaccine 24: 561–571. doi:10.1016/j.vaccine.2005.08.060. 
23.  Wang L, Zeng G, Lee LA, Yang Z, Yu J, et al. (2003) Progress in Accelerated Measles 
Control in the People’s Republic of China, 1991 – 2000. J Infect Dis 187: 252–257. 
24.  Zhuo J, Geng W, Hoekstra EJ, Zhong G, Liang X, et al. (2011) Impact of supplementary 
immunization activities in measles-endemic areas: A case study from Guangxi, China. 
J Infect Dis 204: 455–462. doi:10.1093/infdis/jir063. 
110 
 
25.  Li H, Wang Q, Shi W, Deng Z, Wang H (2015) Residential clustering and spatial access 
to public services in Shanghai. Habitat Int 46: 119–129. 
doi:10.1016/j.habitatint.2014.11.003. 
26.  Gong P, Liang S, Carlton EJ, Jiang Q, Wu J, et al. (2012) Urbanisation and health in 
China. Lancet 379: 843–852. doi:10.1016/S0140-6736(11)61878-3. 
27.  Pan WY, Cai ZK, Chen JL, Zhou Y, Huang LF, et al. (2014) Epidemiological 
characteristics of measles in non-target population before and after measles vaccine 
Supplementary Immunization Activities in Fujian Province China. Chin J Biol 27: 
932–939. doi:10.13200/j.cnki.cjb.000455. 
28.  Zhang L (2001) Strangers in the City: Reconfigurations of Space, Power, and Social 
Netowrks within China’s Floating Population. Stanford, CA: Stanford University Press. 
29.  Greenwood B (1999) The Epidemiology of Pneumococcal Infection in Children in the 
Developing World. Philos Trans Biol Sci 354: 777–785. 
30.  Hu X, Xiao S, Chen B, Sa Z (2012) Gaps in the 2010 measles SIA coverage among 
migrant children in Beijing: Evidence from a parental survey. Vaccine 30: 5721–5725. 
doi:10.1016/j.vaccine.2012.07.007. 
31.  Hou Z, Jie Chang, Yue D, Fang H, Meng Q, et al. (2014) Determinants of willingness to 
pay for self-paid vaccines in China. Vaccine 32: 4471–4477. 
doi:10.1016/j.vaccine.2014.06.047. 
32.  CDC (2012) Pneumococcal disease. Epidemiology and Prevention of Vaccine-
Preventable Diseases. pp. 233–248. 
33.  Zhang L (2009) Building a better infectious disease surveillance system for China. 
Saarbrücken, Germany: VDM Verlag Dr. Müller. 
34.  Bakhache P, Rodrigo C, Davie S, Ahuja A, Sudovar B, et al. (2013) Health care 
providers’ and parents' attitudes toward administration of new infant vaccines--a 
multinational survey. Eur J Pediatr 172: 485–492. doi:10.1007/s00431-012-1904-4. 
35.  World Health Organization (2011) News in Brief. Measles-Rubella Bull 5: 1–9.  
 
 
 
 
  
 111 
 
 
 
 
 
 
APPENDIX A 
English Questionnaire 
 
  
112 
 
 
 113 
 
 
114 
 
 
 115 
 
 
116 
 
 
 
 117 
 
 
118 
 
 
 
 119 
 
 
120 
 
 
 
 121 
 
 
 
122 
 
 
 
 123 
 
  
124 
 
 
 
 
 
 
APPENDIX B 
 
Chinese Questionnaire 
 
  
 125 
 
 
 
126 
 
 
 127 
 
 
 
128 
 
 
 129 
 
 
 
130 
 
 
 
 131 
 
 
132 
 
 
 
 133 
 
 
